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Local and Systemic Effects of Flavonoid Intake with Submaximal  
Cycling Exercise: A Randomized Controlled Trial 
by 
Stephanie Kung, Doctor of Philosophy 
Utah State University, 2021 
Major Professor: Dr. Robert Ward 
Department: Nutrition, Dietetics, and Food Sciences 
Submaximal endurance exercise is a known cause of elevated gastrointestinal 
permeability, injury, and inflammation, which may contribute to symptoms such as 
intestinal cramps and diarrhea. Preclinical and some clinical studies suggest that dietary 
flavonoids, a class of plant secondary metabolites, may regulate intestinal permeability, 
reduce chronic low-grade inflammation, and modulate the intestinal microbiota. The 
purpose of this study was to determine the local and systemic effects of flavonoid intake, 
in addition to cycling performance. A randomized, double blind, placebo controlled 
crossover trial was conducted with 12 recreational cyclists (eight men, four women) from 
August 2018 to May 2019 (ClinicalTrials.gov identifier: NCT03427879). Subjects were 
randomized to a treatment sequence and consumed a high or low flavonoid (490 or 5 
mg), pre-workout beverage daily for 15 days. At the end of each intervention, a 
submaximal cycling trial (one hour at ~70% maximal oxygen capacity) was conducted in 
a controlled laboratory setting (23 °C). Plasma samples were collected pre- and post-
iv 
exercise (immediately, 1-h post, 4-h post). Primary outcomes were intestinal injury and 
permeability, assessed by within-subject comparisons of plasma intestinal fatty acid-
binding protein and urinary sugar excretion. Due to the contribution of the microbiota to 
host metabolism, additional studies of the intestinal microbiome, short chain fatty acid 
excretion, and plasma metabolomics were conducted.  
Food frequency questionnaires estimated total flavonoid intake at 635 ± 195 mg 
per week. Overall, subjects had low intestinal inflammation, and no differences in short 
chain fatty acids or alpha and beta diversity were found. The treatment tended to increase 
force applied during cycling (p = 0.051; effect size, d = 0.16). Despite observing exercise 
effects on biomarkers, no treatment effects were found for intestinal permeability or 
injury (p > 0.05). Circulating carbohydrates, lipids, and amino acids changed to varying 
degrees following exercise, suggesting that multiple fuel substrate pathways were utilized 
throughout exercise and recovery. 
Sub-chronic supplementation with blueberry, cocoa, and green tea flavonoids did 
not significantly affect intestinal health in recreational cyclists. For high intensity 
exercise, a high flavonoid beverage performed as well as the control and did not alleviate 
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PUBLIC ABSTRACT 
Local and Systemic Effects of Flavonoid Intake with Submaximal  
Cycling Exercise: A Randomized Controlled Trial 
Stephanie Kung 
Moderate to high intensity endurance exercise is a known cause of exercise-
induced gastrointestinal syndrome, a condition often associated with intestinal complaints 
such as discomfort, cramps, and diarrhea. Oftentimes, elevated intestinal inflammation 
and permeability (a “leaky gut”) are also observed. Previous research has shown that 
flavonoids, natural compounds found in many fruits and vegetables, may mitigate these 
exercise-induced effects. In particular, certain cocoa powders contain high levels of 
flavonoids, and chocolate milk is a good source of protein and sugars for sustaining 
intense activity. Thus, the purpose of this study was to evaluate the effects of a dairy pre-
workout beverage, with flavonoids from cocoa, blueberries, and green tea. We 
hypothesized that regular consumption of these flavonoids would alleviate exercise-
induced gastrointestinal syndrome. A clinical trial was conducted with twelve subjects, 
who consumed the pre-workout once per day. After 14 days, subjects completed a one-
hour cycling test to determine the effects of the beverage on performance and 
gastrointestinal health. Each participant underwent both the treatment and control in a 
randomized order, serving as his or her own control for comparison.  
Our results showed that the cycling trial was strenuous and caused measurable 
changes in biomarkers of inflammation and intestinal injury, but ultimately, the flavonoid 
pre-workout did not differ from the control. These findings suggest that short-term 
vi 
flavonoid supplementation from processed food ingredients (cocoa powder, freeze-dried 
blueberries, and powdered green tea) may not have protective effects on the gut during 
exercise-induced stress. However, the product was well-liked by the subjects and no 
negative effects were observed. Nutritional strategies for reducing incidence of exercise-
induced gastrointestinal syndrome is a relatively new area of research, and these results 
can help shape future recommendations in sports nutrition for endurance athletes and 
coaches. This project contributes to current scientific knowledge regarding the interaction 
between flavonoid consumption and intestinal health. Furthermore, similar mechanisms 
are thought to drive related conditions such as exertional heat stress, ulcerative colitis, 
and inflammatory bowel disease. Due to the prevalence of a leaky gut and inflammation 
in not only endurance exercise but also these other conditions, more research—especially 
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Bill Rodgers, four-time winner of both the Boston and New York City marathons, 
said that “more marathons are won or lost in the porta-toilets than at the dinner table.” 
The “runner’s trots” (acute exercise-induced diarrhea) and other gastrointestinal (GI) 
complaints commonly occur during long distance running and other endurance sports [1]. 
For example, in one ultramarathon, 85% of athletes reported experiencing debilitating GI 
symptoms, resulting in reduced nutritional intake during the race and recovery period [2]. 
These GI symptoms are thought to be driven by the physiological changes that occur 
during high-intensity exercise, during which core temperature steadily rises and oxygen 
availability in the intestinal tissues decreases [1,3,4]. Other contributors to GI distress 
may include mechanical (e.g., posture, repetitive movement), dietary (e.g., high fat, fiber, 
or fluid intake), and neuroendocrine (e.g., cortisol secretion) factors [4].  
Furthermore, intense exercise greater than 70% of maximal oxygen uptake 
(VO2max) and core temperatures above 39.5 °C consistently result in elevated GI 
permeability and inflammation, both of which may contribute further to the etiology of 
GI distress [1,5,6]. Gastrointestinal permeability refers to the movement of small 
molecules across the GI epithelium, the largest interface between the external 
environment and internal milieu; the intestinal epithelium is a selectively permeable 
membrane that regulates the absorption of water, ions, and nutrients while excluding pro-
inflammatory agents [7]. While mild GI symptoms are an inconvenience and may impact 
athletic performance, exercise-induced intestinal injury and elevated permeability may 
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result in the passage of exogenous toxins, microorganisms, and antigens that can further 
compromise an athlete’s overall health by triggering a systemic inflammatory response 
[8].  
Currently, effective nutritional interventions are limited, though many different 
products, including bovine colostrum [9], probiotics [10], glutamine [11], nitrate [12], 
and carbohydrates [13], have been investigated. A growing body of work suggests that 
flavonoids, a diverse class of secondary metabolites abundant in fruits and vegetables, 
may have the potential to alleviate exercise-induced GI inflammation and permeability 
[14]. Findings from in vitro and animal studies suggest that flavonoids can modulate 
intestinal permeability via the intestinal microbiota and tight junction protein complexes, 
while downregulating pro-inflammatory pathways [15–23]. A variety of flavonoids have 
also been effective in preventing or treating cell culture and animal models of 
inflammatory bowel disease (IBD), a condition which also is driven by gut inflammation 
and barrier dysfunction [24–27].  
However, observations from cell culture and animal studies do not always 
translate to the same effect in the human context, and few human clinical trials have been 
conducted [14]. In the Polyphenol Study, a randomized controlled trial (RCT) previously 
conducted at Utah State University, dietary polyphenols (a larger class of molecules that 
includes flavonoids) were demonstrated to have a protective effect on the intestinal 
barrier. Chronic administration of a high flavonoid diet (HFD) reduced gut permeability 
and inflammation in obese and overweight humans (unpublished data)—a population that 
displays elevated intestinal permeability and chronic low-grade inflammation [7,28]. As 
intestinal permeability has also been observed to increase with age, another crossover 
3 
trial provided a high polyphenol diet to a population of older subjects (≥ 60 years) and 
reported an improvement in intestinal permeability in subjects with high baseline 
permeability [29]. We hypothesize that these reductions in GI permeability will translate 
to endurance athletes, who are also known to experience an impaired GI barrier as 
discussed previously.  
Although previous clinical trials have evaluated flavonoid supplementation in 
combination with exercise, study endpoints were generally markers of oxidative stress, 
and evaluations of GI permeability or injury were not included [30–35]. There were, 
however, two recent clinical trials conducted with healthy subjects, investigating 
polyphenol intake with exercise-induced GI permeability and inflammation as primary 
endpoints. First, Szymanski et al. demonstrated that 3-day supplementation with the 
polyphenol curcumin reduced markers of GI damage and the inflammatory response 
following 60 minutes of moderate-intensity running in hot environmental conditions [36]. 
Second, two weeks of moderate flavonoid intake reduced intestinal permeability both at 
rest and after 45 minutes walking at ~60% VO2max, though not following a 2.5 hour run 
at ~70% VO2max [37]. Taking the findings from pre-clinical studies together with these 
recent human studies, dietary flavonoids are a promising intervention to address the 
effects of exercise in the GI tract.  
Advancements in high-throughput technology and data processing has enabled 
scientific inquiries with “-omics” techniques, allowing investigators to gather more 
detailed information regarding individuals’ microbiomes and metabolomes. 
Metabolomics is a comprehensive analysis used to detect and identify all small molecules 
within a biofluid or tissue, and can provide a picture of the real-time metabolic response 
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to a combination of external and internal stimuli [38]. The GI tract is colonized by a 
dynamic community of commensal microorganisms—the gut microbiota—that performs 
many essential functions for the host such as vitamin synthesis and nutrient metabolism 
[14,39]. The intestinal microbiome is a key mediator in the effects of the diet. 
Microbiome analysis attempts to characterize the diversity and abundance of these 
microorganisms within a sample, as well as compare the community structures between 
samples [40]. In the lower GI tract, flavonoids are extensively metabolized to a variety of 
intermediates and products, and even dependent on the microbiota to be transformed to 
more bioavailable and bioactive metabolites [41,42]. Conversely, flavonoid intake can 
also shape the composition of the intestinal microbiome—dietary changes can begin to 
alter the intestinal community in as little as one day [42,43]. Furthermore, the effects of 
dietary flavonoid intake may be highly individualized. Recent microbiome analyses have 
revealed a significant effect of inter-individual variation in responding to dietary 
interventions [14,29]. Systemic effects of flavonoid intake are mediated by metabolites 
(requiring metabolomics analysis), which depend in part on the functions of each 
individual’s intestinal microbiota (requiring microbiome analysis) [44]. As a result, a 
study of the physiological effects of flavonoid intake would greatly benefit from 
including supplementary microbiome and metabolomics analyses. 
The overall hypothesis of this project is that sub-chronic supplementation of 
flavonoids will ameliorate exercise-induced gut injury, permeability, and inflammation. 
Because of the close interaction between the gut microbiome and human health, we 
conducted secondary analyses on the effects of flavonoid supplementation on the gut 
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microbiome, fecal short chain fatty acid (SCFA) content, and plasma metabolomics 
profile. The project objectives were as follows: 
1. Formulate a dairy-based, pre-workout beverage that includes flavonoids from 
blueberry, cocoa, and green tea at a level similar to those provided in prior clinical 
studies where reductions in gut permeability were previously demonstrated.  
2. Conduct a RCT with trained cyclists to determine the effect of sub-chronic 
consumption of the flavonoid sports nutrition beverage on gut permeability, 
injury, inflammation, and performance during an exercise time trial.  
3. Determine the effect of chronic consumption of the flavonoid sports nutrition 
beverage compared to a low flavonoid control on microbiome composition, SCFA 
production, and the plasma metabolome.  
The overall goal of our research is to investigate the effects of bioactive 
compounds on intestinal health. To this end, it is important to understand the local and 
systemic effects of dietary flavonoids. The results from this project will further our 
understanding of the interactions among dietary flavonoids, the gut microbiota, and the 
GI barrier. If proven effective, such a product could potentially benefit athletes and other 
individuals displaying elevated GI permeability, which is also commonly reported in 
exertional heatstroke, septic shock, irritable bowel syndrome, celiac disease, food 
allergies, obesity, and inflammatory bowel disease [45–50]. Research in these areas is 
ongoing, as several of these conditions still lack an effective nutritional treatment 
[45,46,51]. Since fluid bovine milk is well-suited for exercise nutrition and generally 
liked among athletes, this presents an opportunity to provide a dairy-based product 
specifically designed to address exercise-related intestinal changes [52]. The dairy 
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industry, nutraceutical companies, and cocoa, tea, and blueberry producers also have 
opportunity to benefit from this research. Finally, research findings could extend 
knowledge of sports nutrition specifically for endurance athletes, as addressing changes 
in gut permeability, injury, and inflammation is a relatively new concern in the field.  
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1. The Gastrointestinal Barrier 
The intestinal epithelium is a selective barrier that separates luminal contents 
(molecules, enzymes, and microorganisms) from internal circulation and consists of a 
single layer of absorptive enterocytes, secretory goblet cells, peptide- and hormone-
secreting enteroendocrine cells, and Paneth cells [1,2]. Adjacent cells are connected 
together at the apical (luminal) surface by tight junctions, which are protein complexes 
comprised of the transmembrane proteins occludin, claudin, tricellulin, and junctional 
adhesion molecules (JAMs) [2–4]. Occludin and claudin are anchored to the cytoplasmic 
zonula-occludin proteins, which are bound to cytoskeletal actin and myosin filaments [2].  
The intestinal barrier plays an important role in regulating the passage of nutrients 
and small molecules from the intestinal lumen to internal circulation [1]. To enter hepatic 
and systemic circulation, luminal contents either pass through intestinal cells 
(transcellular route) or the interstitial space between cells (paracellular route) (Figure 2-1) 
[3]. Disruption of this selective barrier can result in unregulated translocation of 
exogenous antigens, toxins, and pathogens, potentially causing local and systemic 
inflammation [2]. A “leaky gut” or increased intestinal permeability, may be caused by 
several factors, including epithelial damage to the mucosal lining or altered tight junction 




Figure 2-1. Structure of the intestinal epithelial membrane and the transcellular and 
paracellular routes of transport.  
 
 
2. Endurance Exercise and GI Distress 
Intensive endurance exercise is known to cause intestinal barrier dysfunction, and 
approximately 30-50% of individuals experience GI symptoms during exercise and 
competition [6]. Gastrointestinal complaints such as abdominal cramps, diarrhea, 
vomiting, and nausea are commonly experienced by endurance athletes [7]. In one study, 
following a bout of high-intensity exercise, symptomatic athletes experienced greater 
intestinal permeability than asymptomatic athletes did [8]. Interestingly, the two groups 
did not differ in baseline gut permeability measured at rest [8]. On the other hand, 
increased gut permeability has also been observed even in the absence of GI symptoms, 
which suggests that even asymptomatic athletes may be at risk of exercise-induced 
intestinal injury [9].  
2.1 Splanchnic Hypoperfusion 
Changes in two physiological factors are thought to cause this dysregulation in 
intestinal permeability during exercise: splanchnic (abdominal) circulation and core body 
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temperature [10,11]. During exercise, up to 80% of splanchnic blood flow is reduced and 
redirected to support active tissues (i.e., cardiac, pulmonary, and skeletal muscle tissue) 
[10]. Splanchnic blood flow has been shown to decrease 30-60% after 30 minutes of 
exercise at 60-70% VO2max [11]. Gut hypoperfusion and ischemia are consequences of 
prolonged, inadequate mesenteric blood flow, leading to low oxygen and glucose 
availability [7,12]. These effects are greater at higher exercise intensities and 
environmental temperatures, and may also be affected by age, prandial state, and training 
status [6,11,13]. Depending on the duration and intensity of exercise, mucosal erosions 
and ischemic colitis have also been reported [7]. Even in mild or less severe cases, 
occurrence of increased intestinal permeability has the potential to hinder athletic 
performance and the subsequent recovery period [7]. 
2.2 Core Temperature 
Secondly, elevated GI permeability is believed to be strongly influenced by 
changes in core temperature [9,14]. During exercise, localized gut hyperthermia occurs as 
core body temperature gradually rises, which causes hypoxia and cellular metabolic stress 
in the splanchnic capillary beds [15]. Enterocytes located at villus tips are particularly 
vulnerable to hypoxia as there is generally lower oxygen availability due to the 
countercurrent exchange in the villi [7,16]. At elevated temperatures of 37-42.5 C, both 
in vitro and pre-clinical studies have shown that the intestinal barrier is compromised 
[3,17–20]. When rats were heat stressed at 42.5 C, Lambert et al. observed epithelial cell 
sloughing, vacuolization, and loss of microvilli [18]. In a systematic review of sixteen 
clinical studies, Pires et al. reported that beyond the threshold temperature of 39 C, 
increased intestinal permeability was always observed following an exercise test [14]. 
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Exercise tests in controlled clinical settings at moderate to high intensities (≥ 70% 
VO2max) have been shown to elevate core temperature to 38.2-39.6 C [21]. In outdoor 
competition, peak core temperatures as high as 41.7 C have been reported [22]. Beyond 
the critical thermal maximum of 41.6 C in humans, sloughing and apoptosis of intestinal 
cells occur, leaving gaps in the barrier, and without rapid intervention, can result in multi-
organ failure and death [3]. 
2.3 Exercise and Endotoxemia 
In some cases of elevated intestinal permeability, paracellular gaps may become 
large enough to permit translocation of intestinal microorganisms or their cellular 
components—particularly lipopolysaccharide (LPS) [13]. LPS is typically present at high 
levels in the intestinal lumen, due to the large population of Gram negative bacteria that 
reside there [23]. However in systemic circulation, LPS is a major activator of the 
inflammatory cytokine response, recruiting leukocytes and promoting the production of 
inflammatory cytokines, nuclear factors, and heat shock proteins [14]. Furthermore, the 
presence of LPS in interstitial fluid and at the basolateral side of the intestinal epithelium 
can induce tight junction permeability by promoting expression of toll-like receptor 4 
(TLR4), the pattern recognition receptor for LPS, which is responsible for activating the 
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) inflammatory 
signaling cascade [23]. In this way, leakage of LPS due to external stresses like exercise 
may result in a prolonged inflammatory response [23]. Higher circulatory levels of anti-
LPS immunoglobulins have been reported in competitive triathletes, potentially due to 
frequent exposure to LPS from intestinal Gram negative bacteria during training and 
exercise [24]. Several studies have reported exercise-induced permeability and 
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endotoxemia (elevated LPS in circulation) in athletes following competition [24–27]. In 
exertional heat stroke, the resulting defects in the intestinal barrier are thought to lead to 
LPS leakage, activation of the inflammatory response, and multiple organ failure [25]. 
2.4 Nutritional Strategies to Mitigate GI Distress 
Though exercise-induced gut permeability is a common occurrence, there are few 
nutritional strategies that have been shown to prevent it, and this may be due in part to the 
fact that the mechanisms are still not well understood [1]. Most recommendations are 
general in nature, such as limiting the intake of high fat, fiber, and protein foods and 
hyperosmotic beverages immediately preceding exercise [6,7,11,28]. During a triathlon, 
incidence of GI symptoms was modestly associated with morning intake of 
carbohydrates, caffeine, and total calories [29]. Dietary recommendations are also 
dependent on the individual’s training habits, dietary preferences, sport, and genetics 
[28]. Some promising strategies have been proposed, though research is still ongoing and 
most nutritional interventions have yielded mixed results.  
First, adequate hydration is essential, as dehydration can further exacerbate 
exercise-induced symptoms [11,13]. Strategic carbohydrate consumption also appears to 
reduce GI symptoms, injury, and inflammation, especially when coupled with “gut 
training” to increase individual tolerance to consuming carbohydrates during exercise 
[30–32]. For example, ingestion of multiple transportable carbohydrates (e.g., 2:1 glucose 
to fructose ratio) versus a single carbohydrate reduces osmotic pressure in the gut and 
may alleviate symptoms [6,30,33]. On the other hand, Sessions et al. found that ingestion 
of a carbohydrate gel during a 60-minute running trial at 70% VO2max increased markers 
of intestinal injury and inflammation compared to a non-carbohydrate control [34]. 
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Another nutritional intervention is to consume compounds such as L-citrulline and 
glutamine that increase nitric oxide (NO) production in the gut to stimulate vasodilation 
and counteract the exercise-induced reduction in splanchnic perfusion [6,26,35,36]. 
However, these studies have also yielded mixed results, and GI complaints also appear to 
associate with the consumption of vegetables containing dietary nitrate [6,33,37]. Other 
potential nutritional strategies under investigation include probiotics and bovine 
colostrum supplementation [38–43].  
 
3. Effect of Flavonoids on Human Health and Exercise 
3.1 Polyphenols and Flavonoids 
Polyphenols are a large class of plant secondary metabolites characterized by one 
or more aromatic benzene rings with two or more hydroxyl functional groups [44]. These 
compounds are produced in plants for a variety of purposes including pigmentation, 
growth, protection from ultraviolet radiation, and microbial or insect resistance [44]. 
Common dietary sources of polyphenols include fruits, vegetables, coffee, and tea, with 
the average individual consuming anywhere from 100 to 2000 mg total polyphenols daily 
[45,46]. Diets rich in polyphenols are associated with a reduction in the risk for several 
non-communicable diseases, presumably due to the antioxidative, anti-inflammatory, and 
antimicrobial properties of polyphenols, and epidemiological data has shown that 
populations consuming diets high in fruits and vegetables have lower risk of chronic and 
degenerative age-associated diseases [5,45,47–51]. Furthermore, a number of studies 
have suggested that plant polyphenols such as procyanidins, (-)epigallocatechin gallate, 
quercetin, and (-)-epicatechin may protect epithelial tissue integrity by regulating tight 
junction protein expression, assembly, and disassembly [5,52–56]. 
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Within polyphenols are four main compound classes: lignans, stilbenes, phenolic 
acids, and flavonoids [44]. Common dietary flavonoids and food sources are listed in 
Table 2-1. In particular, flavonoids, which comprise the major group within polyphenols, 
have been of interest in health and nutrition research because of their non-nutritive 
bioactive properties—health-promoting effects beyond basic nutritional needs [45,57]. 
Flavonoids are characterized by two aromatic rings connected by a 3-carbon bridge (C6-
C3-C6) and further categorized in to six sub-classes: flavonols, flavanols, flavanones, 
flavones, anthocyanins, isoflavonoids [55]. Flavanols and anthocyanins are the most 
abundant polyphenols in the human diet [45].  
Polyphenols are chemically classified as radical scavenging molecules and metal 
ion chelators, but due to their low bioavailability and low levels in plasma and tissues, 
their health effects in vivo are more likely via modulation of cellular metabolism and 
signaling [46]. Maximum plasma levels of polyphenol metabolites in comparison to those 
of endogenous phenols and antioxidants (e.g., ascorbate, p-hydroxyphenyl lactate, p-
hydroxyphenyl pyruvate, tyrosine, homogentisic acid, α-tocopherol) (~0.1-22 µM versus 
160-380 µM, respectively) also suggest that it is unlikely that polyphenols themselves are 
significant contributors to total antioxidant capacity as direct antioxidants [58]. One 
possible exception is in the intestinal lumen where flavonoids are present at higher 
concentrations and may act directly to chelate redox-active metal ions and scavenge free 
radicals [59]. Findings from cell culture and pre-clinical studies suggest that flavonoids 
(both purified compounds and polyphenolic plant extracts) have protective effects on the 
intestinal barrier, enhance tight junction complex formation, and reduce intestinal 
inflammation [53,60–63].  
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Table 2-1. Common dietary flavonoids and food sources [44,64].  
 
Flavonoid  Example compounds Dietary sources 
Simple Flavonoids   




Green tea, apple, red wine, cocoa 
 
Flavones Luteolin, Apigenin Herbs and spices; parsley, 
capsicum pepper, celery 
Flavonols Kaempferol, Quercetin, 
Myricetin 
Ubiquitous in plant foods; onions, 
leeks, broccoli, cherry tomato, 
apple, berries, beans, tea and red 
wine 
Flavanones Hesperetin, Naringenin, 
Eriodictyol, Tangeritin 
Citrus fruits and herbs (oregano) 
Isoflavones Genistein, Daidzein Soybeans, soy-based foods 
Anthocyanins Delphinidin, Pelargonidin, 
Cyanidin, Malvidin, 
Petunidin 
Red, blue, and purple fruits and 
berries; wine, blackcurrant, 
cherry 








Chocolate, stone fruit, grapes, 
strawberries, nut skins, beer, 
wine, legumes 
 
3.2 Effects on GI Permeability: Tight Junctions 
The potential regulatory pathways for the effects of polyphenols at the intestinal 
epithelium were discussed in depth by Yang et al. [5]. First, dietary flavonoids such as 
anthocyanins and quercetin have been shown to inhibit NF-B signaling, a key 
transcription factor involved in many inflammatory pathways, and tumor necrosis factor 
alpha (TNF-), a pro-inflammatory cytokine [5]. In addition to the transcription of pro-
inflammatory cytokines, chemokines, cell adhesion molecules, and acute phase proteins, 
NF-B activation appears to disrupt the intestinal barrier; inhibition of NF-B signaling 
by pyrrolidine dithiocarbamate resulted in increased expression of the tight junction 
proteins occludin and zonula occludens-1 (ZO-1) [5]. Epicatechin, a flavan-3-ol 
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commonly found in cocoa, can prevent TNF- barrier disruption through NF-B 
inhibition [56]. Anthocyanins have also been shown to inhibit membrane 
permeabilization by TNF- and activate cellular kinases like p38-MAPK which regulate 
tight junctions [65,66]. In another study, anthocyanin supplementation in mice mitigated 
high fat diet-induced intestinal permeabilization and increased tight junction protein 
expression via production of the intestinal hormone GLP-2 [65]. Other potential 
mechanisms of polyphenols acting at the intestinal epithelium include regulation of 
protein kinase pathways, reduction of reactive oxygen species (ROS), and suppression of 
cellular enzymes like protein phosphatase 2A and Rho GTPases—all of which have 
downstream effects on tight junction permeability [5,66]. 
3.3 Effects on GI Permeability and Inflammation 
Polyphenols and polyphenol-derived metabolites have been shown to be likely 
regulators of intestinal permeability in preclinical models, but overall, human clinical 
data regarding flavonoid supplementation to mitigate intestinal inflammation and 
permeability is limited [62,67]. Curcumin, a polyphenolic compound found in turmeric, 
may have beneficial effects on exercise-induced inflammation and intestinal permeability 
in hot environmental conditions (20 C vs. 37 C) [68,69]. Short term, 3-day 
supplementation with 500 mg/day of curcumin reduced measures of intestinal injury and 
thermal strain during one hour of sub-maximal treadmill running in hot conditions (37 
C) in non-heat acclimated subjects [69]. Typically, plasma I-FABP, an indicator of 
intestinal injury, is elevated following exercise, but this effect was blunted with curcumin 
supplementation compared to placebo (58% vs. 87% increase from pre-exercise values, 
respectively) [69]. Physiological strain index (PSI), an indicator of exertional heat stress 
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risk, is determined from core temperature and heart rate, and the PSI was significantly 
lower with curcumin supplementation than placebo during the last 20 minutes of the 
exercise test [69]. 
Previously, a study conducted at USU (the Polyphenol Study) demonstrated the 
efficacy of chronic consumption of dietary flavonoids in reducing measures of gut 
permeability and inflammation in human subjects (unpublished data). A randomized, 
double-blind, crossover trial was conducted with two six-week treatment periods 
separated by a washout period. Overweight and mildly obese subjects were recruited for 
this study, as this population is known to exhibit chronic low-grade intestinal 
inflammation [1,70]. A well-controlled whole foods diet was provided to participants 
who consumed either 340 mg total flavonoids per 1000 kcals on the high flavonoid diet 
(HFD) or 10 mg per 1000 kcals on the low flavonoid diet (LFD). The two macronutrient-
matched diets differed in only flavonoid content. The results in Table 2-2 show that the 
HFD reduced gastrointestinal permeability compared to the LFD as determined by the 
urinary sugar permeability test relative to mannitol excretion. Furthermore, fecal levels of 
calprotectin, myeloperoxidase, and eosinophil protein X were also significantly lower 
with the HFD treatment, which suggests that dietary flavonoids may reduce intestinal 
inflammation. (Calprotectin, a peptide released by activated neutrophils, is a biomarker 
for gut inflammation that is stable even at room temperature and resists proteolytic 
degradation [2]. Both myeloperoxidase, an enzyme secreted by neutrophils, and 





Table 2-2. Effects of HFD and LFD on markers of intestinal permeability and 
inflammation (unpublished data). 
 
Endpoint LFD HFD P-Value 
Sucrose/Mannitol 0.0057  0.0007 0.0031  0.0003 0.009 
Lactulose/Mannitol 0.022  0.003 0.014  0.002 0.007 
Sucralose/Mannitol 0.055  0.005 0.043  0.003 0.03 
Fecal Calprotectin (g/g) 3.7  0.4 1.7  0.2 < 0.0001 
Fecal Myeloperoxidase (g/g) 51.8  16.9 18.0  7.5 0.01 
Fecal Eosinophil Protein X (g/g) 26.1  10. 7.5  1.6 0.04 
 
3.4 Effects on Exercise: Performance and Recovery 
 Flavonoid supplementation may potentially enhance exercise performance by 
delaying onset of fatigue and also improve recovery following training [58]. The 
mechanisms are thought to be due to the action of flavonoids on several pathways related 
to oxidative stress and inflammation: enhancement of endothelial function and muscle 
perfusion by the NO pathway, activation of endogenous antioxidant systems via the 
Nuclear factor erythroid 2-related factor 2 (Nrf2) and antioxidant response element 
(ARE) pathway, inhibition of cyclooxygenase enzymes (COX1 and COX2) to activate 
anti-inflammatory pathways, and downregulation of NF-κB signaling [58].  
3.4.1 Vascular Function 
Findings from clinical studies have shown that polyphenol supplementation can 
improve flow mediated dilation (FMD), a marker for vascular function, through increased 
NO synthesis and availability [72–74]. Nitric oxide is a potent vasodilator, which affects 
cardiac output, tissue perfusion, and subsequently athletic performance [58]. As 
discussed previously, one of the nutritional strategies under investigation for mitigating 
exercise-related intestinal symptoms involves foods and supplements that increase NO 
production and availability in epithelial tissue, to increase tissue perfusion and improve 
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oxygen availability [26,33,35,36]. Polyphenols may reduce ROS such as superoxide, and 
limiting superoxide can increase NO availability [58]. In addition, polyphenols may also 
activate endothelial nitric oxide synthase 3 (eNOS) to increase NO production [58].  
Several polyphenol-rich fruits have been investigated for their potential as 
ergogenic aids due to their effects on vascular function [75–77]. In a clinical trial with 
seven days of Montmorency cherry powder supplementation (463 mg polyphenols/day), 
overall 15-km cycling time trial (TT) performance was improved by 4.6% [75]. Resting 
tissue oxygenation index, a measure of muscle oxygenation, was significantly higher with 
the Montmorency cherry intervention relative to the placebo (70% vs. 69%). In another 
study, acute cranberry and grape seed polyphenol supplementation (600 mg) increased 
FMD at rest in elite athletes, but there was no effect of the polyphenol extract on 3-km 
cycling TT performance [76]. Finally, acute pomegranate extract intake (1000 mg) 
significantly increased blood flow and vessel diameter following repeated sprint ability 
testing on a cycle ergometer [77]. These findings suggest that polyphenols may increase 
muscle oxygenation through the NO-mediated pathways as discussed previously. 
3.4.2 Oxidative Stress 
Another potential effect of polyphenols on athletic performance is believed to be 
through modulation of redox status. Polyphenols can activate native antioxidant systems 
and downregulate ROS-generating enzymes such as NADPH oxidase [58]. During 
exercise, ROS are produced and increase with exercise intensity, and excess generation of 
ROS during high intensity, long duration exercise may slowly drain performance capacity 
as endogenous antioxidants are depleted [58,78]. This redox imbalance is believed to 
cause quicker fatigue due to vasodilation, reduced calcium sensitivity in active muscle 
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tissues, and increased central fatigue via the somatosensory cortex [58]. Dietary 
polyphenols are thought to activate the adaptive stress response by acting as oxidative 
stressors which modify and inhibit Keap1, an inhibitor of the transcription factor Nrf2 
[79]. Upon degradation of Keap1, Nrf2 translocates to the nucleus to activate the ARE 
transcriptional pathway, which ultimately has downstream effects of promoting 
endogenous antioxidant enzymes like catalase and glutathione peroxidase (Figure 2-2). 
An upregulation in native antioxidants via Nrf2 and ARE signaling most likely occurs 
with chronic polyphenol supplementation longer than three days [58]. 
 
Figure 2-2. Regulation of the Keap1/Nrf2/ARE pathway via oxidative stressors such as 





In one study, 30-day supplementation with lychee fruit polyphenols (~66 mg/day) 
increased submaximal running time to exhaustion [80]. During the study, participants 
maintained their regular exercise routines, and VO2max did not change significantly over 
the 30-day period for the lychee treatment group. The lychee treatment significantly 
increased the subjects’ anaerobic threshold, a common indicator of endurance capacity, 
while neither the placebo nor a vitamin C and E treatment had an effect on running 
performance. The authors proposed that the outcomes of the polyphenol treatment were 
likely due to the modulation of multiple redox signaling pathways rather than through 
direct free radical scavenging, which would have been the expected mechanism driving 
any effects of the vitamin treatment [80]. Several other studies have demonstrated that 
polyphenol intake may reduce exercise-related oxidative stress, though no performance 
changes were observed [81–85]. For example, dark chocolate consumption (2 weeks, 40 
g twice daily) significantly reduced markers of oxidative stress (F2-isoprostanes and 
oxidized low density lipoproteins) after an exhaustive endurance cycling trial [81]. 
However, no differences in time to exhaustion at 90% VO2max were observed between 
the dark chocolate treatment and the cocoa liquor-free control. 
3.4.3 Inflammation 
Under normal conditions, the inflammatory response is a rapid, regulated, and 
coordinated response to external or internal perturbations; tissue damage, pathogen 
invasion, and exercise are common activators of inflammation [64]. The inflammatory 
response is characterized by a series of cascading events: release of pro-inflammatory 
molecules, recruitment of specific leukocytes, increased expression of oxidative enzymes, 
and production of anti-inflammatory mediators once the initial insult is under control 
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[64]. During exercise, skeletal muscle releases the cytokine interleukin (IL)-6, 
proportional to relative exercise intensity and duration [86,87]. Heat stress and increased 
GI permeability will further elevate IL-6 production [88]. IL-6 has been implicated in 
both pro- and anti-inflammatory pathways depending on the target tissues and is involved 
in energy substrate mobilization (gluconeogenesis and lipolysis), glucose uptake, and 
lipid oxidation [88,89]. Muscle-derived IL-6 is particularly important during endurance 
exercise for regulating muscle function and exercise capacity by mediating osteocalcin 
production, which acts on muscle tissue to increase exercise capacity [87]. Other 
circulating cytokines that increase following exercise include IL-1ra, IL-10, IL-8, and 
monocyte chemotactic protein (MCP-1) [89]. 
Polyphenols can act in several ways to reduce inflammation. First, polyphenols 
can inhibit NF-B signaling, a key transcription factor involved in many inflammatory 
pathways [90]. Polyphenols can also downregulate expression of the pro-inflammatory 
enzymes cyclooxygenase (COX), lipoxygenase (LOX), and phospholipase A2 (PLA2), 
which ultimately reduces the release of several pro-inflammatory molecules: arachidonic 
acid, prostaglandins, and leukotrienes [90]. 
Polyphenol intake has been shown to mitigate inflammatory stress with a 
multitude of different clinical study designs: free-living and controlled diets, healthy 
subjects and those with chronic diseases, short- and long-term interventions [64]. In a 
meta-analysis by Peluso et al., 32 placebo-controlled clinical trials showed a decrease in 
circulating TNF-α as a result of chronic flavonoid supplementation [91]. In some exercise 
studies, a polyphenol intervention resulted in lower levels of IL-6 following exercise 
[83,91–94]. In one study, the effect of six-week blueberry consumption on oxidative 
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stress and inflammation was evaluated in a group of trained runners [84]. Following a 
2.5-hour treadmill run at 72% VO2max, the anti-inflammatory cytokine IL-10 and natural 
killer cell counts (related to anticancer activity) were elevated, while oxidative stress 
(urinary 5-OHMU and plasma F2-isoprostanes) was reduced.  
In another study, investigators aimed to determine the effects of Cavendish 
bananas, mini-yellow bananas, a carbohydrate beverage, and water on inflammation and 
plasma metabolites prior to and following a 75 km cycling TT [31]. (Cavendish and mini-
yellow bananas have similar carbohydrate content, but mini-yellow bananas have 
approximately 63% higher polyphenol content.) Investigators reported that COX2 mRNA 
expression was reduced in THP-1 monocytes cultured in plasma collected during the 
recovery period from the banana treatments, suggesting that plasma metabolites 
following banana ingestion can downregulate COX2, potentially mediating exercise-
induced inflammation in monocytes. It should be noted that bananas also contain other 
components in addition to polyphenols (e.g., amino acids, dopamine, serotonin, 
vitamins), and the specific banana metabolites resulting in COX2 inhibition were 
unknown. Additionally, both banana treatments and the carbohydrate beverage reduced 
inflammatory markers (IL-6, IL-10, IL-1ra, leukocyte counts) to a similar extent, which is 
consistent with findings from previous studies regarding the immunomodulatory effects 
of carbohydrate intake during exercise.  
 
4. The Gut Microbiota and Dietary Flavonoids 
4.1 Introduction to the Gut Microbiota 
 The intestinal microbiota is a dynamic community of microorganisms that occupy 
the GI tract (primarily the colon) and includes bacteria, Eukarya, and Archaea [95]. These 
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microorganisms are thought to have co-evolved in a symbiotic relationship with their 
human hosts [95]. Within an individual, the diversity and composition of the gut 
microbiota are relatively stable by two to three years of age, but large shifts may still 
occur due to host and environmental perturbations such as dietary changes, illness, and 
antibiotics treatment; given time, the composition of the intestinal microbiota will return 
to normal [95]. The intestinal microbiota can be profiled using metagenomic sequencing 
of the 16S ribosomal ribonucleic acid (rRNA) gene [95]. Over 1,000 different species 
have been found colonizing the human intestinal tract, and collectively, they have a 
combined metagenome and metabolic capability 100-times greater than their human host 
[96]. Microbiota diversity varies substantially from one individual to another—though 
there are similarities in a few resident microorganisms and the functional genome, or 
microbiome [96]. The human gut microbiota primarily consists of bacteria from the phyla 
Firmicutes (49-76%), Bacteroidetes (16-23%), Proteobacteria (~8%), and Actinobacteria 
(~3%), and the proportions of these microorganisms also vary depending on the location 
within the GI tract [97].  
An important part of the human intestinal ecosystem, the gut microbiota has been 
found to play a key role in several functions and processes. Some metabolic activities of 
the microbiota include the catabolism of indigestible carbohydrates and proteins, 
xenobiotic transformation, and vitamin synthesis [96]. Microbial degradation of these 
nutrients, xenobiotics, and drugs may increase or decrease the bioavailability and activity 
of these exogenous compounds [97]. The microbiota is also known to provide benefits to 
the host by reducing pathogen adhesion, supporting immune system development, and 
regulating intestinal permeability [95]. Additionally, the microbiota may also interact 
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with epigenetic modifications and plays a part in maintaining immune homeostasis [95]. 
Individuals with immune, inflammatory, or metabolic diseases often display gut 
dysbiosis, or an imbalanced microbial population [95].  
 One important function of the gut microbiota is aiding in the development of a 
mature intestinal epithelium and maintaining the integrity of the barrier [98]. In the GI 
tract, a mucus layer consisting of cross-linked mucin glycoproteins is secreted by 
specialized epithelial cells and aids in protecting the host from pathogen invasion; 
conversely, a compromised mucus layer results in increased pathogen susceptibility and 
localized inflammation [99]. Germ-free mice display thinner colonic mucus and epithelial 
cell dysfunction, but following colonization with conventional microflora, the integrity of 
the intestinal epithelium can be restored [99]. In one study, when dietary fiber was 
restricted, rapid and reproducible shifts were observed in the intestinal microbiota in mice 
[99]. Instead, certain strains of commensal bacteria that ordinarily rely on dietary fiber 
for energy shifted to metabolize mucin glycoproteins, degrading the protective mucus 
layer and increasing susceptibility to pathogen invasion [99]. In contrast, Akkermansia 
spp. are mucin-degrading commensal bacteria that are believed to help with maintaining 
the protective mucus layer by stimulating further mucus production and may also exhibit 
anti-inflammatory effects in the GI tract [100].  
Due to the complex nature of the intestinal microbiota, more clinical studies are 
needed to elucidate how exercise stress impacts the microbiota and intestinal 
permeability. In a study by Karl et al., a strenuous 4-day cross-country ski-march induced 
a significant increase in intestinal permeability concomitant with a change in the 
intestinal microbiota [101]. The exercise regimen negatively impacted the microbiota by 
33 
reducing abundance of Bacteroides while increasing the abundance of potentially harmful 
microorganisms (Peptostreptococcus, Staphylococcus, Peptoniphilus, Acidaminococcus, 
and Fusobacterium) [101]. In contrast, Codella et al. have suggested that moderate 
exercise can positively shape the microbiota to improve chronic disease health outcomes 
due to the release of exercise-associated myokines, reduced intestinal transit time, overall 
weight loss, and increased fecal bile acids as a result of exercise [102]. In another study, 
exercise improved intestinal health in mice fed a high fat diet by modulating the 
microbiota, reducing COX-2 expression in the proximal and distal gut, and preserving 
normal intestinal villi morphology compared to sedentary animals [103]. Regular 
exercise is also positively associated with the presence of microbial species that promote 
barrier integrity (e.g., Akkermansia muciniphila, Lactobacillus plantarum, Bacteroides 
fragilis, Bifidobacterium longum, Bifidobacteria bifidum) and appears to increase overall 
microbial alpha diversity [104,105].  
4.2 Short Chain Fatty Acid Production 
Another function of the colonic microflora is the catabolism of indigestible 
carbohydrates to produce short chain fatty acids (SCFA) [106]. The three most abundant 
SCFA are acetate, propionate, and butyrate—typically present in the GI tract in a ratio 
ranging from 3:1:1 to 10:2:1 [107]. Ultimately, these SCFA have different metabolic 
fates: butyrate is primarily utilized as an energy source for colonocytes, propionate is 
absorbed through hepatic circulation by the liver, and acetate is metabolized by 
peripheral tissues such as the brain, muscle, pancreas, and adipose tissue [106]. Other 
aspects of the biological significance of colonic SCFA production are less clear and more 
research is still needed. Potentially, these exogenous SCFA produced by the colonic 
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microflora from undigested material result in greater dietary energy available to the host 
[108]. If so, excessive SCFA production may contribute to the development of obesity, as 
greater production of total SCFA has been observed in obese and overweight humans 
[108]. However, findings from observational studies also suggest that increased fiber 
intake, which subsequently increases SCFA production, results in improved health 
outcomes [108]. In fact, in colorectal cancer, the protective effect of fiber intake has been 
attributed to butyrate production by the intestinal microbiota [108]. 
Though not yet fully understood, microbial SCFA are increasingly being 
recognized as important signaling molecules between the microbiota and host [106]. 
Many of the microbiota-associated changes observed in human health may in fact be 
mediated through the action of SCFA. The SCFA-specific free fatty acid receptors 2 and 
3 (FFAR 2/3) have been identified across various tissue and cell types, and the 
downstream effects of these receptors appear to be substrate- and tissue-dependent [106]. 
In the liver, acetate and butyrate are lipogenic while propionate is gluconeogenic and 
inhibits lipogenic effects of acetate [106]. Increased circulating SCFA is associated with 
lower adipogenesis and reduced lipid accumulation in adipocytes, resulting in smaller 
adipocytes [106]. Acetate can also stimulate leptin secretion in adipocytes, which is a 
hormone that regulates satiety [106]. Butyrate has received significant attention for its 
potential in protecting the intestinal barrier—it appears to regulate the tight junction 
protein complex by increasing expression and assembly of tight junction proteins like 
claudin-1, ZO-1, and occludin [106,109,110]. Butyrate may also have anti-inflammatory 
and anti-cancer properties [98]. In a mouse model of colitis, microbial-derived butyrate 
was shown to activate regulatory T cells via epigenetic modification of the Foxp3 gene, 
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reducing development of colitis [111]. Interestingly, exercise can positively affect the 
presence of butyrate-producing bacteria in the gut like Lachnospiraceae and 
Faecalibacterium prausnitzii [104]. 
Finally, SCFA production can also shape the composition of the microbiota by 
reducing the growth of potentially pathogenic species [108]. A diet rich in fiber and 
carbohydrates was shown to lead to a greater production of SCFA and consequently, a 
reduction in intestinal and colonic pH, creating an environment unfavorable for the 
growth of many common human pathogens like E. coli and Enterobacteriaceae [112].  
4.3 The Reciprocal Relationship Between Flavonoids and the Gut Microbiota 
 The relationship between dietary flavonoids and the intestinal microbiota is 
complex and bidirectional: dietary flavonoids can shape the diversity and composition of 
the microbiota and the microbiota is responsible for the metabolism and transformation of 
dietary flavonoids [113]. Only ~5-10% of flavonoids are absorbed in the small intestine, 
and those that are not absorbed in the small intestine are extensively metabolized by the 
colonic microflora [114]. The colonic microbiota can increase compound bioavailability 
through enzymatic catabolism into lower molecular weight metabolites, which can be 
either more or less bioactive than the parent compounds [114]. Consequently, the 
microbiota are likely mediators in the health effects exerted by dietary polyphenols [114].  
A schematic of the host and microbiota co-metabolism of dietary flavonoids is 
presented in Figure 2-3. In the small intestine, most flavonoids are deglycosylated by the 
brush border enzyme lactase-phlorizin hydrolase (LPH), and a small proportion are 
absorbed by epithelial cells and transformed to glucuronide, sulfate, and methylated 
conjugates through phase II metabolism [115,116]. Native polyphenols and their 
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conjugates can reach maximal levels in the plasma between 0.5-9 hours after ingestion 
[58,117]. In the colon, ingested flavonoids undergo ring fission and are extensively 
metabolized by the colonic microflora to phenolic acids, hydroxycinnamate, 
phloroglucinol, and other compounds [118]. In addition, phase II flavonoid-derived 
metabolites excreted through the enterohepatic pathway into the lower GI tract are 
subject to further biotransformation by the microbiota [118]. Microbial polyphenol 
metabolites appear in systemic circulation 6-48 hours after ingestion, and display 
significant variation among subjects, likely due to large inter-individual differences in 
intestinal microflora [58,119]. Additionally, microbial transformation has been found to 
be dependent on the degree of polymerization and structure of the polyphenol, as larger 
polymers may result in limited accessibility for microbial catabolic enzymes or reduced 
cellular uptake. For example, lower bioavailability was observed with procyanidin dimers 
and polymers compared to epicatechin monomers [120]. Nonetheless, given the highly 
adaptive nature of the microbiota to dietary changes, the gut microbiome may also be 
able to adapt to metabolize larger proanthocyanidin oligomers and polymers [121]. 
Microbial metabolism is a key step in making more bioactive metabolites available to 
tissues and organs beyond the intestinal tract. Without the action of the microbiota, not 
only would flavonoid metabolite absorption be severely limited, but so would the 
potential downstream systemic effects.  
Since the microbiota can have a variety of effects on the human host, flavonoid-
mediated modification of the microbiota population can affect a large array of health 
outcomes. Flavonoids have well-documented anti-microbial properties and can inhibit 
both pathogenic and beneficial microorganisms [122]. Conversely, specific flavonoids 
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can also act to increase the abundance of certain microbial species within the intestinal 
community, while other flavonoids may have both inhibitory and stimulatory effects on 
different strains [97,123,124]. These effects appear to be structure-dependent and 
aglycones may have greater inhibitory activity than their glycated counterparts [125]. 
Additionally, dietary flavonoids can also increase or inhibit bacterial adhesion, affecting 
the presence and diversity of species in the intestinal tract [123]. 
 
Figure 2-3. Host and intestinal microbiota co-metabolism of dietary flavonoids and their 
downstream effects. 
 
Preclinical studies have demonstrated that polyphenol-rich extracts show potential 
to modulate Akkermansia muciniphila abundance and mucin protein expression, though 
more clinical data is still needed [65,126]. A polyphenolic cranberry extract ameliorated 
the obesogenic effects of a high fat/high sucrose diet (weight gain, visceral obesity, 
triglyceride accumulation, insulin resistance), reduced intestinal inflammation and 
metabolic endotoxemia, and increased the abundance of Akkermansia spp. in mice [127]. 
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Similarly, supplementation with grape polyphenols in mice blunted the negative 
metabolic effects of a high fat diet while increasing the abundance of Akkermansia spp. 
[128]. In another rodent study, supplementation of a high fat diet with blueberries 
changed the microbiota composition while preserving ileal villus morphology and 
increasing Muc2 gene expression relative to a pair-fed, high fat diet group [129]. 
Additionally, the probiotic Lactobacillus plantarum also modulates the epithelial barrier; 
treatment of IL-10 knockout mice, which display colonic barrier dysfunction compared to 
wild type mice, with Lactobacillus plantarum significantly reduced the severity of colitis 
development and paracellular permeability [130]. In other rodent studies, 
supplementation with bilberry anthocyanin extract, apple procyanidins, and green tea 
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EFFECT OF FLAVONOID SUPPLEMENTATION ON EXERCISE-INDUCED 
INTESTINAL INJURY, PERMEABILITY, AND INFLAMMATION 
Introduction  
 The gastrointestinal (GI) barrier is a selectively permeable membrane that 
facilitates water and nutrient uptake while excluding potentially harmful antigens and 
pathogens [1]. Intestinal permeability refers to the movement of luminal contents to the 
internal milieu through either the epithelial cells lining the GI tract or the interstitial space 
between neighboring cells, which is regulated by tight junction protein complexes [1]. 
Both external and internal stimuli can affect intestinal permeability, and elevated 
permeability is a common feature of several autoimmune, intestinal, and metabolic 
diseases and conditions [1].  
In particular, high intensity endurance exercise causes transient, increased 
intestinal permeability [2]. Severe or prolonged exercise-induced intestinal permeability 
can be problematic and cause local and systemic inflammation—potentially hindering 
physical performance and recovery [3]. At rest, 20% of total cardiac output is directed to 
the splanchnic organs; during exercise, up to 80% of this blood flow is shunted to muscle 
and other peripheral tissues instead [4]. Prolonged hypoperfusion of visceral tissues 
causes localized hypoxia and mucosal injury, and reperfusion injury can occur due to 
reactive oxygen species (ROS) accumulation and localized inflammation [4]. Exercise 
intensity is thought to be one factor affecting intestinal permeability. In a study by Pals et 
al., participants ran for 1 hour at 40, 60, and 80% VO2max, and a significant increase in 
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intestinal permeability relative to baseline was only observed after running at 80% of 
VO2max [5]. Second, heat stress has also been demonstrated to cause epithelial cell 
injury and disrupt tight junctions both in vitro and in vivo; thus, the magnitude of change 
in core temperature is another important factor in exercise-induced intestinal permeability 
[2]. A systematic review of human exercise studies by Pires et al. reported a positive 
association between magnitude of core temperature change and increased intestinal 
permeability [4]. In studies where post-exercise core temperatures were above 39 °C, 
increased intestinal permeability was always observed [4].  
Several dietary nutrients have been shown to regulate intestinal permeability [6]. 
Specifically, flavonoids (plant secondary metabolites abundant in fruits and vegetables) 
have been demonstrated to modulate tight junction permeability through several 
mechanisms in vitro [7]. Flavonoids can activate the nuclear factor erythroid 2-related 
factor 2 (Nrf2) pathway which upregulates endogenous antioxidant capacity, and 
flavonoids also have anti-inflammatory activity through the downregulation of nuclear 
factor kappa B (NF-κB) signaling (see Chapter II, Section 3) [7–9]. Dietary flavonoids 
also exhibit other beneficial effects through NO-related mechanisms—including 
vasodilation, regulation of glucose uptake, and improved endothelial function [9,10]. 
Given these various biological activities and the positive health outcomes commonly 
observed with flavonoid-rich dietary patterns, flavonoids are thought to have great 
potential as protective agents for the intestinal barrier [11,12]. Furthermore, the 
vasoactive, antioxidant, and anti-inflammatory effects of flavonoid consumption may 
also enhance exercise performance and improve recovery by increasing muscle perfusion 
and delaying onset of fatigue [10].  
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Consequently, the purpose of this study was to determine the effects of sub-
chronic (fifteen-day) consumption of a high flavonoid pre-workout beverage (HFB) on 
GI permeability and inflammation following a bout of high-intensity endurance exercise. 
The flavonoid content of the investigational product was formulated to provide a 
moderate dose of flavonoids in one serving (490 mg/day). Previous clinical studies 
investigating flavonoid supplementation and exercise performance span a range of doses 
from relatively low to several times higher (100-2000 mg/day); however, a review of 
these studies concluded that a dose of ~300 mg polyphenols consumed 1-2 h prior to 
exercise may be sufficient to improve endurance and repeated sprint performance [10]. 
Our primary endpoint was intestinal injury as indicated by plasma intestinal fatty acid-
binding protein (I-FABP). Secondary endpoints included intestinal permeability (excreted 
urinary sugars), inflammatory response (circulating cytokines), and cycling performance 
(work output and cycling distance). Based on prior work, we hypothesized that the HFB 
would ameliorate exercise-induced intestinal injury and permeability relative to a low 
flavonoid control (LFB). Resilience to exercise-induced changes in GI permeability may 
also result in a reduction in acute exercise-associated inflammation and improved cycling 
performance. 
 
Materials and Methods 
Ethical approval 
This study was conducted in accordance with the 2008 Helsinki Declaration for 
Human Research Ethics and approved by the Utah State University (USU) research ethics 
committee (IRB Protocol #9255). Participants were informed of all study requirements 
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and provided written informed consent prior to enrollment. This study was registered at 
ClinicalTrials.gov prior to study start (ClinicalTrials.gov Identifier: NCT03427879). 
Participants 
For a complete study recruitment flow diagram, see Appendix A, Figure A-1. 
Participants were recruited by word of mouth and through advertisements posted at local 
cycling businesses and gyms in Logan, Utah and at USU (Appendix A, Figure A-2). 
Seventeen cyclists were screened for study eligibility, and of those, fourteen subjects 
were enrolled and randomized to treatments. One subject dropped out due to scheduling 
conflicts, and one subject was withdrawn due to failure to adhere to the study protocol. 
Twelve recreational cyclists (female n = 4, male n = 8; mean ± SD: age 37 ± 11 years, 
body mass 78 ± 13 kg, height 1.74 ± 0.09 m, VO2max 43 ± 6 ml/kg/min) completed both 
arms of the study.  
 




















1 49 68.5 161.5 26.3 43.9 130 10 
2 33 100.0 183.6 29.7 39.3 180 . 
3 43 58.2 158.1 23.3 41.4 105 15 
4 36 87.0 182.1 26.2 42.6 160 . 
5 40 87.7 179.9 27.1 51.4 215 23 
6 45 69.7 165.5 25.4 41.0 145 12 
7 18 72.8 182.7 21.8 46.5 165 12 
8 33 99.4 173.1 33.2 28.1 145 1 
9 55 79.6 179.0 24.8 43.5 160 10 
10 40 69.1 178.2 21.8 46.2 160 5 
11 18 69.1 165.0 25.4 44.1 165 6 









25.6 ± 3.3 43.2 ± 5.9 160.8 ± 
29.3 
11.4 ± 6.7 
Range 18-55 58.2-100 158.1-
183.6 





 Eligibility and general health were assessed with a participation readiness 
questionnaire (PAR-Q) and health screening assessment. A complete list of study 
inclusion and exclusion criteria is provided in Appendix A, Table A-1. Briefly, key 
inclusion criteria were as follows: male or female of any race or ethnicity, age 18-55 
years, training at least 3 times per week, participated in a cycling event in the past 12 
months, and free of chronic disease and GI conditions. Exclusion criteria included a 
medical history of heart disease, hypertension, diabetes, Crohn’s disease, IBS, colitis, 
celiac disease, inflammatory or autoimmune disease, allergies to pre-workout ingredients, 
and/or lactose intolerance. Participants were also excluded for chronic use of NSAIDs, 
flavonoid supplement consumption < 1 month prior, or antibiotic use < 3 months prior. 
For women, additional exclusion criteria included those who were pregnant, 
breastfeeding, or < 6 months postpartum.  
Preliminary assessments 
During the screening period, each participant completed a maximal aerobic 
capacity (VO2max) test via expired gas analysis to determine power settings for the two 
subsequent cycling trials. This preliminary test also allowed participants to be 
familiarized with the Velotron cycle ergometer (SRAM LLC; Chicago, IL). The 
incremental graded VO2max test began at 100 Watts (W) and increased by 25 W/min 
until either volitional exhaustion or rpm < 60. Expired gas samples were collected using a 
two-way valve mouthpiece (Hans Rudolph 700 series; Kansas City, MO), and oxygen 
consumption was recorded with a computerized on-line metabolic measurement system 
(Parvomedics TrueOne 2400; Sandy, UT). After the test and a ten-minute rest, a follow-
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up assessment was performed to validate the predicted power (W) at 70% VO2max for 
steady state exercise (fixed power). Power settings were adjusted in 5 W increments as 
needed to achieve 70% VO2max for a minimum of 3 minutes before the final power 
setting for the exercise trials was determined.  
Participants also performed a baseline intestinal permeability assessment with an 
overnight, 8-hour urine collection. For the test, participants fasted four hours following 
their evening meal. After 4 hours, participants emptied their bladder and drank a 130 ml 
sugar solution containing 10 g sucrose, 5 g lactulose, 1 g maltitol, and 1 g sucralose. (The 
intended sugar permeability test includes mannitol, but due to a supplier error, maltitol 
was provided instead.) For the next eight hours, urine was collected in a 3 L container 
with 50 µl of 10% thymol as a preservative. During this time, participants were only 
permitted to drink water. In the morning, participants voided into the collection jug and 
recorded the total volume. A subsample (50 ml) was aliquoted to another container, and 
samples were stored frozen for future analysis.  
Investigational product 
For each intervention, participants were provided with fifteen individual servings 
of pre-workout mix (containing all dry ingredients in Table 3-2), shelf-stable 2% white 
milk, and a shaker bottle. Instructions provided to the participants for preparing the pre-
workout are included in Appendix A, Figure A-3. One package of pre-workout mix (64 
g) was prepared with 240 ml milk and consumed once per day, two hours prior to 
exercise or the subject’s typical exercise time. One serving of the high flavonoid 
beverage (HFB) provided approximately 490 mg total flavonoids, while the low 
flavonoid beverage (LFB) contained approximately 4.6 mg flavonoids due to three 
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modifications: alkalized cocoa, blueberry placebo powder, and omission of green tea 
powder. The green tea extract contained approximately 800 mg/g tea catechins 
(PureBulk, Inc; Roseburg, Oregon). High flavonoid cocoa powder (83 mg/g cocoa 
flavanols) and alkalized cocoa (10 mg/g flavanols) were provided by Barry Callebaut 
(Zurich, Switzerland). Freeze-dried blueberry powder (14.0 mg/g total anthocyanins) and 
blueberry placebo powder were supplied by the US Highbush Blueberry Council 
(Folsom, California). 
 
Table 3-2. High flavonoid beverage (HFB) and low flavonoid beverage (LFB). 
 
Ingredient HFB % (w/w) Ingredient LFB % (w/w) 
2% Milk 78.1 2% Milk 78.2 
Sugar 8.6 Sugar 8.6 
Maltodextrin 8.6 Maltodextrin 8.6 
Blueberry powder  2.4 Placebo powder  2.4 
Cocoa powder 1.6 Alkalized cocoa powder 1.6 
Whey protein isolate 0.6 Whey protein isolate 0.6 




The primary endpoint of this study was I-FABP detected in the plasma, a non-
invasive biomarker of intestinal injury and permeability [3]. I-FABP is a cytosolic protein 
expressed in mature small and large intestinal enterocytes and present only at low levels 
in the plasma unless released from injured or lysed cells [3]. Because circulating I-FABP 
is rapidly cleared and has a half-life of only eleven minutes, the change in I-FABP from 
baseline is an early marker for intestinal injury [13]. Circulating I-FABP correlates 
strongly with abdominal trauma, appearance of inflammatory markers, determination of 
gut ischemia with gastric tonometry, and the severity of morphologic epithelial intestinal 
damage [3,14]. (In gastric tonometry, a tonometer balloon is inserted with a catheter into 
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the gastric cavity to detect accumulated CO2 in the gut mucosa due to underperfusion 
[3].)  
The second endpoint was the urinary excretion of orally-ingested sugars (sucrose, 
lactulose, and sucralose)—a non-invasive method to determine GI permeability. Sucrose, 
which is digested by the enzyme sucrase in the small intestine, is an indicator of gastric 
permeability, lactulose is fermented by the microbiota in the colon and therefore indicates 
of small intestinal permeability, and sucralose is non-digestible, so recovered sucralose in 
the urine reflects overall GI permeability [1,15].  
The plasma cytokines TNF-, IL-6, and IL-10 were selected as secondary 
endpoints. The pro-inflammatory cytokine TNF- increases the rate of epithelial cell 
turnover and activates opening of the tight junction, leaving gaps in the intestinal barrier 
[1,16]. IL-6 is secreted from skeletal muscle during exercise in response to heat stress and 
low energy availability [17]. It can also affect gastric emptying and plays an important 
role in attenuating intestinal permeability and mucosal injury caused by a dangerous rise 
in core temperature [18]. Lastly, IL-10 is an anti-inflammatory cytokine promoted by IL-




Figure 3-1. Schematic overview of crossover study design with low flavonoid beverage 




The study design was a randomized crossover trial, with a minimum fourteen-day 
washout between the two intervention periods (Figure 3-1). Following completion of 
screening and baseline assessments, each participant was randomly assigned a treatment 
order. With the exception of high flavonoid foods, flavonoid supplements, and NSAIDs, 
participants were free to consume their regular diet and maintain their usual training 
schedule. In addition, participants were instructed to abstain from alcohol and strenuous 
activity 24 hours prior to each urine collection and cycling trial. Gut permeability 
assessments using orally-administered sugar test probes and an overnight eight-hour urine 
collection were performed at baseline and on Day 12 of each intervention. On Day 15, a 
gut permeability assessment was also performed immediately following the trial with a 
six-hour urine collection. Meals consumed during these periods were recorded and 
replicated during the second intervention. Each intervention concluded with a one-hour 
cycling trial on Day 15, during which blood samples were collected pre-, post-, 1 h post-, 
and 4 h post-exercise. The schedule for clinic assessments and specimen collections is 
provided in Appendix A, Figure A-4. A pre-loaded time trial (TT) was selected for the 
study, as it has been shown to produce more reliable performance results in test-retest 
designs and also provides quantitative endpoints of work and distance [19]. In contrast, 
within-subject designs with fixed cycling intensities (e.g. 1 hour at 70% VO2max) 
typically produce greater variation and are more prone to being affected by psychological 
factors [19]. 
Main exercise visit 
On Day 15, two hours prior to the cycling trial, participants consumed their 
typical pre-race breakfast (recorded and replicated for Phase 2), the HFB/LFB pre-
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workout, and an ingestible temperature sensor pill (CorTemp, HQ Inc.; Palmetto, FL). At 
the clinic, subjects emptied their bladders, body mass was measured, and a blood sample 
was taken. Subjects warmed up for five minutes at a self-selected pace prior to starting 
the cycling trial. The trial consisted of 45 minutes cycling at a fixed power (70% 
VO2max), followed by a fifteen-minute “all out” time trial (TT), during which subjects 
were free to adjust the power setting and rode at maximal effort to complete as much 
work (J) as possible. Throughout the exercise test, heart rate and core temperature were 
recorded at five minute intervals, and a final core temperature measurement was taken 
five minutes after completion of exercise. Rating of perceived exertion (RPE) was 
recorded at minutes 5, 15, 25, and 35, and expired air was collected to determine VO2 at 
10, 20, 30, and 40 min. The visual RPE scale presented to subjects is included in 
Appendix A, Figure A-6. Subjects were provided with a small amount of room 
temperature water (0.5 ml/kg bodyweight) at 15 minutes. Following the trial, participants 
were seated and another blood sample was collected. Participants then ingested the gut 
permeability sugar solution and collected urine for six hours. During the first two hours, 
subjects were only permitted to drink water, and certain foods and beverages were 
restricted to minimize interference with the test. All meals and snacks were recorded in a 
food log and repeated during the second intervention. Two final blood samples were 
collected one and four hours post-exercise. Adverse events and symptoms experienced in 
the 24 hours following the exercise test were noted with brief questionnaire. A sample 




Blood sampling and analysis 
Seated venous blood samples were collected via antecubital venipuncture in 
K2EDTA-treated Vacutainer tubes and centrifuged (1500 × g, 10 min, 4 °C). Plasma was 
aliquoted to 1.5-ml polypropylene microcentrifuge tubes and stored frozen at -80 °C until 
further analysis.  
A commercial enzyme-linked immunosorbent assay (ELISA) kit was used for 
determination of plasma I-FABP in duplicate (Hycult Biotech; Uden, The Netherlands). 
High sensitivity ELISA kits were used to analyze TNF-α and IL-10 according to the 
manufacturer’s instructions (Invitrogen; Carlsbad, CA). Plasma IL-6 cytokine analysis 
was conducted with an ELISA kit according to the manufacturer’s instructions 
(Invitrogen; Carlsbad, CA). 
Urine sugar analysis for gut permeability 
Urinary concentrations of each of the sugar probes (i.e., recovery of the sugars in 
urine specimens) were determined with gas chromatography-mass spectroscopy (GC-
MS) analysis following trimethylsilyl (TMS) derivatization. Due to the low 
concentrations of recovered sugars, urine samples were spiked with 7.5 ppm sucrose, 2 
ppm sucralose, and 20 ppm lactulose prior to drying and derivatization to increase the 
signal to noise ratio for the measurement. For the standards, a synthetic urine matrix was 
prepared with 0.33 M urea, 0.12 M sodium chloride, 0.016 M potassium diphosphate 
(KH2PO4), 0.007 M creatinine, and 0.004 M sodium monophosphate (NaHPO4). 
Additionally, inositol was added to all samples as an internal standard (50 µl, 1 mg/ml). 
Samples were prepared in duplicate, and 400 µl of urine or 800 µl of a 1:1 standard and 
synthethic urine mix were evaporated to dryness in a speed vacuum centrifuge. After 
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drying, 100 µl of O-methoxylamine (CH3ONH2) in pyridine (20.0 mg/mL) was added to 
each sample and mixed thoroughly. Samples were heated at 70 C for 1 hour. After 
heating, samples were centrifuged at 13,000 x g for 5 minutes, and 50 µl of the 
supernatant was combined with 50 µl of N,O-Bis(trimethylsilyl)trifluoroacetamide 
(BSTFA). The samples were heated again for 30 minutes at 70 C and then transferred to 
a glass sample vial for GC-MS analysis.  
The GC-MS platform was a Shimadzu single quadrupole gas chromatograph mass 
spectrometer (GCMS-QP2010 SE) with a Zebron ZB-5MS plus (35 m × 0.25 mm 
diameter × 0.25 μm film thickness) capillary GC column (Phenomenex, Torrance, CA, 
USA). Helium was used as the carrier gas, and the column flow rate was 1.16 ml/min, 
with a split ratio of 5:1. The temperatures of the inlet, ion source, and transfer line were 
250 °C, 230 °C, and 290 °C, respectively. The column oven temperature program is 
included in Table 3-3. Compound peak areas were normalized by the inositol internal 
standard, and sugar concentrations were determined from standard curves (Appendix A, 
Table A-2). Recovered sugar concentrations were corrected to the actual concentration by 
subtracting the spiked concentration. Corrected concentrations were multiplied by total 
urine volume to determine recovered mass which was used to determine percent urinary 
recovery from the initial amount of sugar ingested.  
 
Table 3-3. Gas chromatography (GC) oven temperature program for sugar separation. 
 
Rate (°C/min) Temperature (°C) Hold Time (min) 
-- 80 0 
20 180 1 
2.5 210 1 
20 245 10 
1 255 0 
20 280 0 
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Sample size 
 A previous study demonstrated a treatment difference of 328.6 ng/ml for change 
in I-FABP following exercise, with patient standard deviation for repeated measurements 
estimated at 389.8 ng/ml [20]. Assuming a similar effect size of 0.84 (α = 0.05), the 
probability is 82 percent that the study will detect a treatment difference with a total of 
fourteen subjects.  
Statistical analysis  
 All data were checked for normality and homogeneity of variance, and data 
violating model assumptions were log-transformed prior to analysis. The TT distance, 
work, and cycling cadence were analyzed with paired t-tests. Cohen’s d (d) was used to 
determine effect size for cycling work output, and a d value of 0.2, 0.5, and 0.8 indicate 
small, medium, and large effect sizes, respectively. Core temperature, heart rate (HR), 
VO2, rating of perceived exertion (RPE), plasma I-FABP, IL-10, IL-6, and TNF-α were 
analyzed using a two-way repeated measures ANOVA. For IL-6 and TNF-α, statistical 
analyses were performed on raw instrumental values. When main or interaction 
(intervention  time) effects were significant, Tukey’s HSD was used for post-hoc 
comparisons, unless otherwise specified. Negative values for sugar recovery were input 
as 0. A one-way repeated measures ANOVA was used to analyze sugar probe recovery 
with condition (baseline, HFB Day 12, LFB Day 12) as the independent factor. Intestinal 
permeability following the exercise trial on Day 15 was analyzed with a paired t-test. 
Correlation analyses (Spearman’s ρ) were conducted to determine if final core 
temperature and change in core temperature correlated with primary outcomes (change in 
I-FABP, post-exercise I-FABP, % sucrose, % lactulose, % sucralose). No significant 
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treatment order effect (HFB-LFB, LFB-HFB) was observed. Data are expressed as means 
± SEM, unless otherwise indicated. Statistical analyses were performed with JMP version 
15.2.1 for Windows (SAS Institute, Cary, NC) with significance at  = 0.05. 
 
Results 
 Both the flavonoid and control pre-workout beverages were well-tolerated by the 
subjects, with no reported adverse effects.  
Physiological responses and exercise performance 
The exercise test elicited a similar response in HR, VO2, and RPE regardless of 
the treatment (Table 3-4, Figure 3-2). There was a significant effect of exercise on HR (p 
< 0.0001), where the HR during the TT (t = 50, 55, 60) was significantly higher than the 
pre-load exercise (t = 5-45). Initial HR (t = 0) was significantly lower than all other time 
points. Likewise, RPE increased during exercise and was significantly elevated at 25 and 
35 min compared to 5 min (p < 0.0001). Final RPE at 35 min was 3.9 ± 0.5 (LFB) and 
4.0 ± 0.4 (HFB), where an RPE of 4 is “somewhat hard”. VO2 was significantly lower at 
10 min compared to all other times (p = 0.0003), but not different between trials.  
For the TT, no differences were observed for cadence (HFB: 93 ± 9 rpm, LFB: 93 
± 11 rpm) or total cycling distance (HFB: 19.3 ± 0.7 km, LFB: 18.9 ± 0.8 km). However, 
a trend for increased work output was observed for the HFB (p = 0.0511, Cohen’s d = 
0.16) (Figure 3-3B).  
A significant effect of time (p < 0.0001) and time × treatment interaction (p < 
0.0001) was observed for core temperature (Figure 3-4A). Core temperature from 10 min 
onwards for both conditions was significantly elevated compared to pre-exercise. 
Pairwise comparisons across condition at each time were not significantly different after 
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correcting for multiple comparisons. A small decline in core temperature was observed at 
20 min when participants were provided water (0.5 ml water/kg bodyweight) after 15 min 
of exercise. The maximum core temperatures immediately following exercise were 38.53 
± 0.06 °C (HFB) and 38.51 ± 0.23 °C (LFB). Overall changes in core temperature from 
pre-exercise (t = -5) to 60 min exercise were 2.24 ± 0.23 °C (LFB) and 1.73 ± 0.13 °C 
(HFB) (paired t-test, p = 0.008) (Figure 3-4B).  
 
Table 3-4. Perceptual and physiological measures: rating of perceived exertion (RPE) and 
VO2 during 1-h cycling trial.  
 




2.9 ± 0.3a 3.2 ± 0.3ab 3.8 ± 0.4b 4.0 ± 0.4b 
2.7 ± 0.4a 3.3 ± 0.4ab 3.6 ± 0.5b 3.9 ± 0.5b 
HFB-LFB 0.3 ± 0.2 -0.1 ± 0.2 0.3 ± 0.2 0.1 ± 0.3 




29.9 ± 1.4a 30.2 ± 1.3b 30.6 ± 1.4b 30.5 ± 1.3b 
29.6 ± 1.4a 30.2 ± 1.5b 30.4 ± 1.4b 30.4 ± 1.4b 
HFB-LFB 0.37 ± 0.58 -0.01 ± 0.46 0.23 ± 0.33 0.10 ± 0.25 
Values with different superscripts differed significantly (p < 0.05). 
 
 







Figure 3-3. Cycling time trial performance. (A) Primary vertical axis: distance completed 
during the 15 min TT (LFB: 18.9 ± 0.8 km, HFB: 19.3 ± 0.7 km). Secondary vertical 
axis: within-subject treatment difference (0.4 ± 0.3 km, p = 0.181). (B) Primary vertical 
axis: work completed during the 15 min TT (LFB: 174.2 ± 11.3 kJ, HFB: 180.9 ± 12.3 
kJ). Secondary vertical axis: within-subject treatment difference (6.6 ± 3.0 kJ, p = 
0.0511). 
 














Figure 3-4. (A) Core temperature during exercise trial. (B) Overall change in core 
temperature during exercise: 2.24 ± 0.23 °C (LFB) and 1.73 ± 0.13 °C (HFB); paired t-








A main effect of time was observed for plasma IL-6 and IL-10 where both 
cytokines were significantly elevated post-exercise and after 1-h recovery (Table 3-5). 
Similarly, TNF-α was elevated immediately post-exercise compared to pre-exercise 




























Table 3-5. Plasma cytokines.  
 
 
 Pre-exercise Post-exercise 
  Immediate 1-h 4-h 
IL-6 
(pg/ml) 
HFB n.d. 0.76 ± 0.23* 0.22 ± 0.13* n.d. 
LFB n.d. 0.79 ± 0.38* 0.53 ± 0.20* n.d. 
HFB-LFB n.d. -0.03 ± 0.42 -0.31 ± 0.19 n.d. 
IL-10 
(pg/ml)   
HFB 1.49 ± 0.36 3.95 ± 0.69* 3.04 ± 0.44* 1.48 ± 0.28 
LFB 1.52 ± 0.38 3.76 ± 0.67* 2.69 ± 0.36* 1.86 ± 0.55 
HFB-LFB -0.02 ± 0.36 0.20 ± 0.69 0.35 ± 0.44 -0.39 ± 0.28 
TNF-α 
(pg/ml) 
HFB n.d. 0.28 ± 0.09* n.d. n.d. 
LFB n.d. 0.31 ± 0.07* n.d. n.d. 
HFB-LFB n.d. -0.02 ± -0.06 n.d. n.d. 
Mixed effects, repeated measures 2-way ANOVA performed on raw instrumental values. 
n.d., not detected. *Significant difference from pre-exercise, p < 0.0001. 
 
 
Gut injury and permeability 
A significant effect of time was observed for plasma I-FABP (p = 0.001), but 
there was no significant treatment effect or treatment × exercise interaction (Figure 3-5). 
Plasma I-FABP was significantly elevated immediately post-exercise compared to all 
other time points. Mean change in I-FABP from pre- to immediately post-exercise did not 
differ between treatments: 300 ± 156 pg/ml (HFB) and 439 ± 162 (LFB) pg/ml. In 
addition, no significant correlation was found between final core temperature or change 
in core temperature and change in I-FABP.  
Percent recovery of 8-h urinary sugars (sucrose, lactulose, and sucralose) at rest 
was not significantly different between condition (baseline, LFB, HFB) (Table 3-6). 
Similarly, percent recovery of 6-h urinary sugars was not significantly different between 
treatments following the exercise trial (Table 3-7). Since a post-exercise sample was 
missing for one subject, these analyses were conducted with n = 11. No significant 
correlation was found between final core temperature or change in core temperature and 
percent recovery of sucrose, lactulose, or sucralose. 
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Figure 3-5. Plasma I-FABP measured at t = 0, 1, 2, 5. Peak values of I-FABP 
immediately post-exercise (t = 1): 1161 ± 253 (HFB), 1177 ± 250 pg/ml (LFB). 




Table 3-6. 8-h Sugar probe excretion at rest, n = 12. 
 
 Baseline HFB (Day 12) LFB (Day 12) p-value 
% Sucrose 0.035 ± 0.010 0.069 ± 0.023 0.056 ± 0.018 0.454 
% Lactulose 0.424 ± 0.087 0.424 ± 0.081 0.324 ± 0.064 0.354 
% Sucralose 1.206 ± 0.210 1.311 ± 0.264 1.237 ± 0.448 0.561 
 
Table 3-7. 6-h Sugar probe excretion post-exercise, n = 11. 
 
 HFB LFB HFB-LFB p-value 
% Sucrose 0.040 ± 0.008 0.066 ± 0.026 -0.026 ± 0.028 0.817 
% Lactulose 0.293 ± 0.050 0.267 ± 0.085 0.026 ± 0.085 0.384 
% Sucralose 0.775 ± 0.060 1.116 ± 0.386 -0.341 ± 0.404 0.994 
 
Discussion 
The purpose of the present study was to determine the effect of flavonoid 
supplementation on intestinal inflammation, injury, and permeability following moderate- 
to high-intensity cycling. On the HFB, recreational cyclists consumed ~490 mg of cocoa, 





























Contrary to our hypothesis, we observed no treatment effects on GI permeability, injury, 
or inflammation. There were no treatment differences between sugar probe recovery 
either at rest or post-exercise and no treatment effects on plasma I-FABP, IL-6, IL-10, 
and TNF-α before and following the exercise trial. Though there was no difference in 
cycling distance or cadence, HFB tended to increase cycling work during the TT.  
The 1-hour cycling trials for both conditions were consistent in degree of exercise 
intensity, with a similar response in RPE and physiological measures of VO2, HR, and 
peak core temperature. Interestingly, we observed a larger increase in core temperature 
for LFB due to a lower initial temperature, regardless of treatment sequence. To our 
knowledge, this difference in initial core temperature potentially due to two-week 
flavonoid supplementation has not been previously reported. However, the maximum 
core temperatures were not different, and since the general practice is to assess final core 
temperature in relation to epithelial integrity, we do not believe that this difference is a 
significant concern in the final outcome.  
Both peak core temperature and exercise intensity (measured by %VO2) have a 
positive association with exercise-induced GI injury and permeability [4,5]. Several other 
cycling studies at similar intensity (70% VO2max) and duration (one hour) reported 
increased GI permeability and injury [21–24]. In the present study, average maximal core 
temperature was 38.52 ± 0.12 °C, and we observed a significant increase in I-FABP 
across both arms from pre- to post-exercise. In a systematic review, Pires et al. reported 
that of participants with a final core temperature of 38.5 °C or below, ~36% showed 
increased permeability, and within the range of 38.6-39.0 °C, ~48% of participants 
showed augmented permeability [4]. Though the cycling protocol employed in the our 
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study was comparable in intensity and demonstrated acute GI injury, on average subjects 
had relatively lower peak core temperatures than those outlined by Pires [4], which may 
be one reason why no treatment effects on I-FABP and intestinal permeability were 
observed. When subjects were grouped into high and low peak core temperatures 
determined by values above and below the median (38.61 °C), no significant effect of 
high or low final core temperature was found for overall change in I-FABP or percent 
sugar recovery. Additionally, no correlations were found between final core temperature 
and primary outcomes. Perhaps if there was a larger effect of exercise, we may have 
observed a difference with the HFB alleviating these acute exercise effects. Additionally, 
6- and 8-h urinary sugar probe excretion may not be as sensitive to modest exercise-
induced changes on intestinal permeability, since relatively transient changes in 
permeability may recover quickly depending on intensity and duration of exercise [22]. 
Other studies have reported detecting exercise-induced changes in I-FABP and serum 
recovery of sugar probes that were not observed in urinary samples [22,25]. In the present 
study, exercise appeared to induce transient intestinal injury, since we only observed 
significant time effects for I-FABP immediately post-exercise, but not one or four hours 
later. Other exercise protocols ranging from 60-120% VO2max have been shown to 
increase I-FABP by 50-250% immediately following exercise [26]. Since the extent of 
intestinal injury due to exercise was relatively moderate (~46% average increase in I-
FABP from pre- to post-exercise), it is not surprising that a treatment effect on sugar 
probe permeability was not detected. Finally, other studies evaluating changes in I-FABP 
following moderate- to high-intensity exercise reported significant post-exercise 
treatment differences of ~300 pg/ml (curcumin supplement vs. placebo), 424 pg/ml (35 
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vs. 20 °C environmental temperature), 328.6 pg/ml (bovine colostrum vs. control), 401 
pg/ml (ibuprofen vs. control), and 186.8 pg/ml (carbohydrate gel vs. placebo) [20,27–30]. 
A post-hoc power calculation was conducted for the post-exercise I-FABP response 
given the achieved sample size and estimated within-subject standard deviation of 380.8 
pg/ml, and this study was powered to detect a treatment effect of ~480 pg/ml, but the 
actual mean difference observed was 16 pg/ml—much smaller than the sampling 
variation observed within subjects, and not likely a clinically meaningful difference had 
there been a true effect.  
Exercise modality is also known to affect the incidence of GI symptoms and 
stress; cycling induces relatively less inflammation, muscle damage, and oxidative stress 
than running [31]. In one study comparing GI permeability during running and cycling, 
running caused a larger increase in intestinal permeability [32]. This may be due to the 
mechanical impact and posture during running which is not as pronounced in cycling 
[33,34]. In previous work conducted with runners, we found that participants struggled to 
complete the designated running test in its entirety (1-h at 80% VO2max), which resulted 
in the trials being cut short, and no significant changes in gut permeability were observed 
(unpublished data). Based on our collaborator’s previous experience, cyclists recruited 
from the local community were expected to be capable of reliably completing the cycling 
protocol. Studies conducted elsewhere have also demonstrated measurable changes in gut 
permeability with cycling [21–24,32].  
Another reason why we may not have observed an effect on intestinal 
permeability and injury is due to differences in flavonoid bioavailability. In the 
Polyphenol Study previously conducted at USU, we observed a significant reduction in 
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intestinal permeability and inflammation with a high polyphenol dietary intervention (340 
mg flavonoids/1,000 kcal) provided to participants through a mixture of fruits, 
vegetables, juice, and chocolate (Chapter II, Section 3.3). In contrast, the investigational 
product in this study was prepared from a mixture of food ingredients with some degree 
of processing (e.g., drying, freeze-drying, extraction). While the flavonoid content of the 
blueberry, cocoa, and green tea powders were supplied by the manufacturers, some 
bioactivity may have been reduced during transit, storage, and any time prior to 
consumption. Bioavailability and bioaccessibility can vary widely from purified 
compounds, to extracts, to fresh whole foods [35]. Compounds in a food matrix can have 
either positive and negative effects in terms of flavonoid bioavailability [36]. Some 
polyphenols such as procyanidins may be less bioavailable when in a food matrix, while 
others may actually be preserved throughout the digestive tract and reach the small 
intestine in a greater quantity due to association with the food matrix [37]. Polyphenols 
ingested in combination or in the form of food along with other dietary components may 
have increased bioavailability or interact to exert synergistic effects [31,38]. Although an 
epicatechin (one of the primary flavan-3-ols in cocoa) supplement was shown to have a 
negative effect on aerobic and mitochondrial adaptations to cycle training in one study, 
others utilizing cocoa products showed neutral or positive effects on performance, 
inflammation, and oxidative stress [39–41]. While we cannot say for certain how the food 
matrix and processing affected bioavailability and bioefficacy of the investigational 
product, we acknowledge that this is a factor that may have impacted the results and one 
reason why the results differed from those of the Polyphenol Study.  
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Recently, Keirns et al. suggested that individuals who train regularly may be more 
resistant to a leaky gut than sedentary individuals when GI integrity is assessed at rest 
versus immediately post-exercise—that is, chronic exercise may improve GI integrity 
over time [42]. This may be another reason why we observed differences between the 
present study with active cyclists and the Polyphenol Study with sedentary, 
overweight/obese subjects. Part of the adaptive response to exercise and heat stress is the 
upregulation of heat-shock proteins (HSP) in muscle and cardiac tissue, which can help 
stabilize cytoskeletal proteins and tight junctions [43,44]. Prior heat stress conditioning 
may increase thermotolerance, cell survival, and resistance to barrier dysfunction, 
through HSP induction [44,45]. For example, an elevation in incubation temperature from 
37 °C to 39 °C increased HSP and tight junction protein (ZO1 and occludin) expression 
after four hours in Caco-2 and HT29 intestinal cells [46]. On the other hand, it has not yet 
been demonstrated that chronic exercise can upregulate HSP expression in intestinal 
enterocytes [42]. More research is warranted, as the data currently available suggesting 
that chronic exercise can reduce intestinal permeability is limited to study populations 
with various metabolic conditions (insulin resistance, type II diabetes, and obesity) [42]. 
These studies also reported reductions in visceral fat mass and body weight over the 
course of the exercise program, which could be the reason for improvements in intestinal 
permeability through reduced circulating inflammatory cytokines [42]. Nevertheless, 
others have suggested that flavonoid supplementation may have a greater protective 
effect in untrained individuals; the effects of flavonoid supplementation on muscle 
mitochondrial biogenesis and performance, if any, may not be as great in trained versus 
untrained individuals, since untrained muscle tissue has a lower mitochondrial density 
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than trained [31]. Competitive athletes, regularly exposed to oxidative stress during 
training, have more active endogenous antioxidant and anti-inflammatory responses and 
increased muscular efficiency from years of consistent endurance training [47,48]. In one 
study, a fruit and vegetable flavonoid powder fed to highly trained cyclists for seventeen 
days did not have an effect on exercise-induced inflammation, but a similar dose of 
flavonoids was previously shown to have an effect in non-athletes [49]. The authors 
suggested that the intervention may not be as effective may be due to the higher level of 
fitness of the study population [49]. In another study, two-week flavonoid 
supplementation decreased intestinal permeability relative to placebo in an untrained 
population both at rest and after walking at ~62% VO2max, while intestinal permeability 
was elevated in a group of trained runners following 2.5 h running at 69% VO2max—
though several other differences between the untrained and trained groups may have 
contributed to the results [50]. In the present study, subjects were trained, recreational 
athletes, with an average maximum aerobic capacity of 43.2 ± 5.9 ml/kg/min (range: 
28.1-51.4 ml/kg/min). The cycling protocol was chosen to elicit final core temperatures 
above 38.5 °C, to increase the likelihood of observing changes in GI permeability [4]. 
Though we may have been more likely to observe an effect of flavonoid intake with 
untrained subjects, they would have been less likely to successfully complete this 
challenging exercise protocol. Also, it may not be as applicable to attempt to alleviate 
these exercise-induced GI changes in untrained individuals who do not exercise or 
compete regularly.  
Physical exertion and hyperthermia are known to cause changes in plasma 
cytokine levels [16,51]. We observed relatively low levels of IL-6, IL-10, and TNF-α 
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despite the rigorous exercise protocol. As expected, plasma I-FABP and IL-6 increased in 
response to exercise and returned to baseline levels during the recovery period, regardless 
of the treatment. However, plasma IL-6 and TNF-α were relatively low even immediately 
following exercise and mostly undetectable at baseline and after 4 hours of recovery. 
Similarly, Osborne et al. found that I-FABP increased 140% from pre- to post-exercise, 
but no change in circulating pro-inflammatory cytokines or endotoxin following a 60-min 
trial at 35 °C (alternating between 40-70% VO2max), with final core temperatures 
reaching 39.5 °C [30]. Other studies with a similar intensity (70% VO2max) reported no 
changes in TNF-α (< 2 pg/ml pre- to post-exercise) and the plasma cytokines IL-10 and 
IL-6 (< 6 pg/ml) despite showing a significant increase in intestinal permeability and core 
temperature of 39.5 °C, respectively [52,53]. Short-term curcumin supplementation 
reduced the increase in I-FABP relative to placebo following a one-hour treadmill run at 
65% VO2max at 37 °C, but no significant interaction effects were observed between the 
treatment and time for IL-6, IL-10, and TNF-α [29]. In contrast, other studies have shown 
exercise effects on circulating cytokines, with varying effects of polyphenol ingestion. 
Two-week supplementation with the flavonoids quercetin and EGCG significantly 
reduced IL-6 and IL-10 but not TNF-α relative to placebo following a daily three-hour 
cycling protocol for three consecutive days [31]. McAnulty et al. found that six weeks of 
blueberry ingestion elevated the anti-inflammatory cytokine IL-10 to a greater extent than 
the control immediately following a 2.5 h run at ~72% VO2max [54]. Based on these 
varied results, it is possible that shorter duration exercise at temperate conditions, such as 
in our study, does not elicit as large of a cytokine response as is more consistently 
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observed in hotter environmental temperatures, longer events, or non-controlled 
environments, such as a road marathon [55]. 
Interestingly, HFB supplementation appeared to result in increased work output 
with no difference in cadence or total distance during the fifteen-minute TT. Further post-
hoc analyses showed that cycling power also tended to be greater in the HFB trial (HFB: 
201 ± 14 W and LFB: 194 ± 13 W, p = 0.051, data not shown). Because cadence was not 
different between conditions, the greater power and work output for the HFB trial was 
likely the result of participants applying more force to the pedals. Given the achieved 
sample size and an estimated within-subject standard deviation of 9.3 kJ for repeated TT 
measurements [56], post-hoc power analysis (α = 0.05, β = 0.80) showed that the study 
was powered to detect a minimum treatment difference of 11.7 kJ. However, the small 
effect size (d = 0.16) suggests that the observed difference in work (6.6 kJ) is not likely to 
have a meaningful impact on overall performance—as was demonstrated with the lack of 
an effect on total distance. If these performance effects are related to other factors that 
require a longer time to show measurable changes, then an effect may have been 
observed with a longer supplementation time. As mentioned previously, dietary 
flavonoids can activate endogenous antioxidant pathways via Nrf2 signaling to reduce 
oxidative stress and improve muscle perfusion through increased NO availability [8,10]. 
Presumably, these vascular and antioxidant improvements would have an effect on 
performance, perhaps through delaying onset of fatigue. A recent review found consistent 
evidence of reduced oxidative stress with both acute and chronic cocoa supplementation, 
but changes in exercise performance and recovery were inconsistent with some studies 
demonstrating improvements while others did not [57]. Some studies found no effect of 
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cocoa intake on inflammatory markers while performance improved [57]. Taub et al. 
reported increased VO2max and maximum power with untrained subjects after three 
months’ dark chocolate supplementation [40]. These improvements in cycling 
performance were observed alongside changes in skeletal muscle cellular metabolism and 
improved oxidative stress status (reduced protein carbonyls and increased glutathione) 
[40]. Another study with moderately active subjects reported greater distance covered 
during a two-minute cycling sprint with two weeks of dark chocolate intake, compared 
against white chocolate and no supplementation, and the authors theorized that the 
improved performance was due to lower oxygen cost (increased gas exchange threshold) 
with dark chocolate [41]. Other studies have found performance benefits with a variety of 
other dietary flavonoids and polyphenols. Morgan et al. observed ~4.6% faster 15 km TT 
performance with Montmorency cherry supplementation (257 mg anthocyanins/day for 
one week) relative to placebo in trained cyclists, which was thought to be driven by an 
improvement in muscle oxygenation due to NO availability and potentially reduced 
oxidative stress [58]. Several studies with both acute and chronic blackcurrant and 
pomegranate anthocyanin supplementation have also demonstrated improved 
performance in both trained and untrained subjects [9]. However, our hypothesis was that 
any observed performance improvements would be driven by a reduction in intestinal 
permeability or GI discomfort, and therefore, our primary endpoints were plasma I-FABP 
and urinary sugars; we did not measure markers of oxidative stress as this was beyond the 
scope of our study. Based on other studies and the effects of flavonoid ingestion on Nrf2 
signaling, it is possible that we would have seen an attenuation in oxidative stress or 
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improvement in tissue oxygenation with HFB, which would help explain the slight 
performance benefits observed. 
A limitation of this study was that there was no monosaccharide available for the 
intestinal permeability assessment. Larger molecules (e.g., lactulose, sucralose, and 
sucrose) travel paracellularly to enter systemic circulation from the intestinal lumen while 
smaller molecules (e.g., mannitol) are absorbed transcellularly [13,59]. As a result, larger 
molecules are indicators for changes in paracellular permeability while smaller test 
compounds control for gastric emptying, epithelial absorptive area, transit time, and renal 
function across individuals [60]. The urinary excretion ratio (the recovery of the larger 
probe relative to the smaller) is most often reported and provides a standardized measure 
of intestinal permeability at the region of the GI tract where the larger probe is absorbed 
[13]. Unfortunately, due to a supplier issue, a monosaccharide probe was not included in 
the intestinal permeability assessment. However, the crossover design of the study still 
allowed for meaningful within-subjects comparisons for percent recovery of the 
disaccharide probes, and some other studies have similarly reported percent recovery of 
disaccharide sugars [5,25,61–65]. Another limitation was that the study design restricted 
comparisons between different urine collections. The sugar excretion test is ideally 
performed fasted to minimize the contribution of dietary sugars, so urine samples 
collected at baseline and mid-intervention were fasted, eight-hour overnight collections. 
The collection immediately following the cycling trial was a six-hour collection (two 
hours fasted) in order to minimize participant burden and shorten the long clinic visit on 
Day 15. As a result, comparisons for intestinal permeability are only made among 
baseline and mid-intervention samples and between post-exercise samples. 
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Finally, another limitation is the potential for carryover effects from one 
intervention to the next. It was important to allow a sufficient length of time for any 
lingering effects of the prior treatment to dissipate prior to beginning the next arm, while 
still being short enough to encourage subject retention. Epithelial intestinal cells undergo 
complete turnover within two weeks [66]. Additionally, a two-week washout was used in 
the Polyphenol Study and no carryover effects were observed. For these reasons, a two-
week washout period was selected for this study. In the statistical analysis, subjects were 
nested within treatment sequence, which accounted for whether the subject was randomly 
allocated to the AB or BA treatment order. No significant sequence effects were found in 
any of the analyses, suggesting that the two-week washout was sufficient to minimize 
potential carryover effects.  
In conclusion, a randomized controlled crossover study was conducted to test the 
effects of a pre-workout high flavonoid beverage in reducing exercise-induced GI 
permeability and injury. During a one-hour, moderate intensity cycling test and TT, the 
HFB performed as well as a standard pre-workout mix. Despite the accumulating 
evidence suggesting potential for improvement of GI permeability, inflammation, and 
athletic performance with supplemental flavonoid intake, we found no differences 
between the treatment and placebo. Though there was potentially an effect of increased 
cycling work, the difference in means relative to error was small, and no difference in 
distance was observed. Due to the importance of addressing epithelial integrity and 
inflammation in not only exercise but also exertional heat stress and inflammatory 
diseases (e.g., inflammatory bowel disease, ulcerative colitis, type I diabetes), more 
work—especially well-controlled human clinical trials—is warranted. Future studies 
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should ideally include measurements of tissue perfusion or vascular effects (e.g., flow 
mediated dilation, tissue oxygenation index), mitochondrial metabolism (e.g., 
mitochondrial density, citrate synthase), and oxidative stress (e.g., glutathione, protein 
carbonyls, total antioxidant status). 
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EFFECT OF FLAVONOID SUPPLEMENTATION ON GUT MICROBIOTA 
PROFILE, SHORT CHAIN FATTY ACID EXCRETION,  
AND INTESTINAL INFLAMMATION 
Introduction 
Intestinal dysbiosis may occur throughout an individual’s lifetime when the 
intestinal microbial community is shifted one way or another, or otherwise displays 
aberrant functioning compared to that of a healthy individual [1]. Though it is unclear 
whether intestinal dysbiosis is a cause or an effect, it is often observed in conjunction 
with inflammatory or metabolic pathologies [1–3]. For example, individuals with low 
microbial richness and diversity display more overall adiposity, insulin resistance, and 
dyslipidemia than those with greater microbial richness [4]. Low microbial diversity and 
dysbiosis are also observed in patients suffering from ulcerative colitis, irritable bowel 
syndrome, colorectal cancer, and inflammatory bowel diseases [2,5,6].  
One contributing factor in shaping the gut microbial composition is the diet [7]. 
For example, high animal protein, carbohydrate, or prebiotic intake can all dramatically 
affect the species present in the GI tract [8]. Because of the impact of the diet on the gut 
microbiota and the gut microbiota on human health, it is important to investigate potential 
dietary strategies that can beneficially modulate the gut microbiota and possibly improve 
health outcomes later in life [1,9]. Dietary flavonoids, plant secondary metabolites 
abundant in fruits, tea, and coffee, have previously been demonstrated to help shape the 
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intestinal microbial population [8]. Due to low bioavailability in the small intestine, the 
majority of dietary polyphenols, which encompass flavonoids in addition to other 
phenolic compounds, transit to the large intestine and are metabolized by the colonic 
microflora [2]. Both parent polyphenols and their metabolites can inhibit or promote the 
growth of different microorganisms [10]. Polyphenols consist of thousands of structurally 
diverse compounds, and different compounds and doses can have varying effects on the 
microbiota [10]. Preclinical and some clinical studies have shown that dietary flavonoids 
can stimulate the growth of health-promoting microorganisms including Lactobacillus 
spp., Bifidobacterium spp., Akkermansia spp., Roseburia spp., and Faecalibacterium spp. 
[2,11–13]. Both Lactobacillus spp. and Bifidobacterium spp. are considered to have 
beneficial effects on intestinal health by reducing pathogen colonization and increasing 
SCFA production [11]. In one clinical trial, ingestion of 494 mg of cocoa flavanols/day 
for four weeks significantly increased Lactobacillus spp., Enterococcus spp. and 
Bifidobacterium spp. compared to a low flavanol control at 23 mg/day [14]. The cocoa 
flavanol treatment also significantly decreased numbers of the C. histolyticum group, and 
changes in the bifidobacteria and lactobacilli significantly correlated with a reduction in 
plasma C-reactive protein (CRP), a marker for inflammation [14]. In another clinical 
study, six-week consumption of a wild blueberry drink containing approximately 375 mg 
anthocyanins and 128 mg chlorogenic acid significantly increased Bifidobacterium spp. 
relative to the placebo [15]. In rats, mango polyphenol supplementation increased 
abundance of Lactobacillus plantarum, Lactococcus lactis, and Clostridium butyrim, 
along with an increase in the SCFAs butyrate and valerate [16]. Other in vitro studies 
have shown that cocoa and tea polyphenols can increase growth of commensal organisms 
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while inhibiting pathogens [17–19]. However, other clinical studies did not find an effect 
of polyphenols on gut microbial composition or SCFA production [20–22].  
An interesting aspect of the interaction of between the intestinal microbiota and 
human health is short chain fatty acid (SCFA) production from non-digestible 
carbohydrates. The microbiota-produced colonic SCFA are believed to act as signaling 
molecules through interaction with specific G protein-coupled receptors and through the 
regulation of gene expression and disease pathogenesis via histone deacetylase inhibition 
[1]. Bacteroidetes are associated with acetate and propionate production while Firmicutes 
are the primary producers of butyrate [1]. Butyrate in particular is an important SCFA, 
because it plays a key role in the differentiation of colonic regulatory T cells, displays 
anti-inflammatory properties, and increases expression of claudin tight junction proteins 
[23–25]. Studies have shown that flavonoid supplementation can increase SCFA 
production, likely due to flavonoid-mediated changes in the microbiota [11]. For 
example, bilberry anthocyanin extract supplementation in rats increased abundance of 
butyrate producers (Lactoacillus and Bacteroides) while inhibiting the growth of harmful 
species (Verrucomicrobia and Euryarchaeota) [26]. (For additional discussion on SCFA, 
refer to Chapter II, Section 4.2.) 
Microbial diversity and their collective, functional genome, which dictates the 
microbiome’s metabolic capability, are closely tied with human health and disease. The 
gut microbiota can affect flavonoid activity by transforming the molecules to more 
bioavailable or bioactive metabolites, so the effects of flavonoid intake on human health 
may be partially mediated by the composition and metabolic activity of the gut 
microflora [3]. Moderate to high dietary flavonoid intake has the potential to positively 
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shape the gut microbiota, but the majority of the evidence is from animal and cell culture 
studies [2]. Similarly, preclinical studies suggest that intestinal SCFA can influence 
signaling of key processes, but clinical data is lacking [27]. As a result, it is important to 
further explore the relationship between flavonoid intake, the gut microbiota, and 
intestinal health in a controlled, human clinical trial. The present study extends previous 
work by exploring intestinal inflammation, microbiota composition, and SCFA excretion 
in response to supplemental flavonoid intake. Based on the literature suggesting that 
flavonoid intake can impact intestinal health, we hypothesized that an increase in dietary 
flavonoid intake of ~490 mg/day would change the proportions of intestinal bacterial taxa 
in a group of healthy volunteers, and that changes observed in the microbiome would also 
be reflected in altered SCFA excretion. Additionally, we hypothesized that elevated 
flavonoid intake would also result in a reduction in intestinal inflammation.  
 
Materials and Methods 
Study design 
This study was conducted in conjunction with the clinical trial as described in 
Chapter III. Briefly, 12 recreationally-active cyclists (female n = 4, male n = 8; mean ± 
SD: age 37 ± 11 years, body mass index 25.6 ± 3.3 kg/m2) completed this randomized, 
controlled crossover study conducted from August 2018 through May 2019 at Utah State 
University (USU). This study was conducted in accordance with the 2008 Helsinki 
Declaration for Human Research Ethics and approved by the USU research ethics 
committee (IRB Protocol #9255). Participants were informed of all study requirements 
and provided written informed consent prior to enrollment. A schematic of the study 
design and endpoint collection is provided in Figure 4-1. 
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A complete list of inclusion and exclusion criteria is provided in Appendix A, 
Table A-1. Exclusion criteria included chronic NSAID use, antibiotics treatment within 3 
months of the study, or flavonoid supplement consumption within 1 month of the study. 
Additionally, those with a medical history of heart disease, hypertension, diabetes, 
Crohn’s disease, IBS, colitis, celiac disease, inflammatory or autoimmune disease were 
also excluded from the study.  
 
Figure 4-1. Schematic overview of crossover study design. 
 
 
A high flavonoid beverage (HFB, 490 mg total flavonoids) or macronutrient-
matched low flavonoid control (LFB, 5 mg flavonoids) was consumed once daily for 
fifteen days. Each serving of the investigational product (64 g powder) was prepared in a 
shaker bottle with 240 ml 2% white milk. During the intervention, participants were 
instructed to abstain from a provided list of high flavonoid foods, flavonoid supplements, 
and NSAIDs. Stool samples were collected once after 9-11 days of supplementation to 
determine fecal calprotectin, microbiota composition, and total SCFA. Participants 
collected stool samples in pre-labelled, freezer-safe containers, and samples were stored 
at -20 °C until the next clinic visit (within four days). Upon receipt at the clinic, samples 
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were homogenized by stirring and transferred to 50 ml tubes and stored at -80 °C until 
further analysis. 
Flavonoid food frequency questionnaire 
Prior to the first screening visit, participants were asked to self-administer a 
flavonoid food frequency questionnaire (FFQ) adapted from Somerset and Papier [28]. 
Subjects indicated their average consumption frequency of eight beverages, three cocoa 
products, seventeen fruits, and thirty vegetables (see Appendix B, Figure B-1). Each food 
serving size was converted to mass (g), and flavonoid content (mg) per 100 g of each 
food or beverage was determined from the USDA Database for Flavonoid Content of 
Selected Foods [29]. Reported food intake frequency was converted to weekly frequency 
for each food/beverage: never or < 1 time/mo = 0.7; 1-3 times/mo = 0.7; 1 time/wk = 
0.43; 2-4 times/wk = 1.7; 1 time/day = 5; 2-3 times/day = 15; 4-5 times/day = 31.5; and > 
6 times/day = 48. Weekly intake frequency of each item was multiplied by the flavonoid 
content to determine total weekly flavonoid intake. 
Fecal calprotectin 
Fecal calprotectin, a protein released by activated neutrophils or during cell death, 
is a reliable biomarker of intestinal inflammation [30]. Fecal calprotectin was determined 
in duplicate with a commercial ELISA kit following the manufacturer’s instructions 
(Hycult Biotech; Uden, The Netherlands).  
Fecal SCFA content 
 All samples and standards were prepared in duplicate. A series of standards (0.04-
5 mM) containing acetic, propionic, butyric, isobutyric, valeric, isovaleric, and caproic 
acids were prepared in deionized water. Ethyl butyric acid was used as an internal 
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standard and prepared at 1 g/L in 250 g/L metaphosphoric acid. Approximately 0.1 g of 
stool was added to 0.9 ml deionized water. After mixing, 200 μl of the internal standard 
was added, and samples were centrifuged at 10,000 × g for 20 min. The supernatant was 
removed and filtered with a 0.2 μm syringe filter into a glass vial. Samples were stored at 
4 °C prior to GC analysis. Analysis was performed with a Shimadzu GC2010 gas 
chromatograph coupled to a flame ionization detector (FID) (Shimadzu Scientific 
Instruments; Columbia, MD). The column was a Zebron ZB-FFAP (30 m × 0.53 mm 
diameter × 1.00 μm film thickness) capillary GC column (Phenomenex, Torrance, CA, 
USA). Hydrogen was the carrier gas, and the column flow rate was 15.94 ml/min, with a 
5:1 split ratio. The temperatures of the injection port and FID were 200 °C and 350 °C, 
respectively. The column oven temperature program used for compound separation is 
shown in Table 4-1. Compound peak areas were normalized by the internal standard and 
concentrations were determined from the standard curves.  
 
Table 4-1. GC oven temperature program for SCFA analysis. 
 
Rate (°C/min) Temperature (°C) Hold Time (min) 
-- 60 1 
17 260 8 
 
Stool microbiota composition 
 Three replicates from each stool collection were prepared for 16S rRNA 
sequencing. Fecal DNA was extracted in duplicate using the DNeasy PowerSoil kit, 
following the manufacturer’s instructions (Qiagen; Carlsbad, CA). Following extraction, 
4 µl of 5 M NaCl was added to each sample. Samples were centrifuged at 10,000 × g for 
5 min, and the supernatant was decanted and residual liquid was removed in a speed 
108 
vacuum evaporator. Precipitated DNA was re-suspended in 10 mM Tris. DNA was 
quantified via absorbance, and samples were normalized to 5 ng/μl in Tris-EDTA buffer. 
Polymerase chain reaction (PCR) amplification of the V3-V4 hypervariable region of the 
16S rRNA gene was completed in triplicate with Platinum Hot Start PCR Master Mix 
(Invitrogen; Carlsbad, CA) and DNA primers (IDT; Coralville, IA). Unique index 
adapters (barcodes) were added to the DNA amplicon with a second round of PCR 
amplification. PCR reaction products were purified, quantified with Quant-iT PicoGreen 
dsDNA Assay Kit (ThermoFisher Scientific, Waltham, MA), and pooled at a final 
concentration of 1 ng/µl. The library pool was spiked with 5% PhiX as an internal control 
and prepared with MiSeq v3 reagents. High through-put sequencing of paired-end 300 
base pair (bp) reads was completed in a single run on the Illumina MiSeq platform at the 
Center for Integrated BioSystems at USU.  
 The raw 16S rRNA amplicon sequencing dataset was processed with Quantitative 
Insights Into Microbial Ecology (QIIME2) [31]. Filtering, dereplication, chimera 
detection, and merging paired-end reads was completed with the Divisive Amplicon 
Denoising Algorithm (DADA2) R package [32]. An amplicon sequence variant (ASV) 
abundance table was generated, and the QIIME feature-classifier classify-sklearn 
command was used with a classifier pre-trained for the V3-V4 region and the most recent 
release of the Silva database [33].  
Observed, Chao1, and Shannon alpha diversity indices were analyzed and plotted 
with MicrobiomeAnalyst [34]. Principal coordinates analysis (PCoA) plots were 




 Data that did not meet assumptions of normality (FFQ and calprotectin) were 
analyzed with the non-parametric Wilcoxon signed-rank test, with false discovery rate 
(FDR) adjustments for multiple comparisons as needed. Since calprotectin values were 
below the assay detection limit, instrumental values were used for statistical testing. 
Mean flavonoid intake determined from the FFQ was compared to the National Health 
and Nutrition Examination Survey (NHANES) reference dataset as reported by Kim et al. 
[36]. Individual and total SCFA were analyzed with paired t-tests, with FDR adjustments 
for multiple comparisons. Microbiome differential analysis was performed with the 
DESeq2 method, with FDR adjustments for multiple comparisons. Group significance for 
beta diversity was determined with permutational multivariate analysis of variance 
(PERMANOVA), with a p-value < 0.01 considered statistically significant. Data are 
expressed as means ± SEM, unless otherwise indicated. Statistical analyses were 
performed with QIIME2, MicrobiomeAnalyst, and JMP version 15.2.1 for Windows 
(SAS Institute, Cary, NC) with significance at  = 0.05, unless otherwise stated. 




 Twelve participants completed both arms of the crossover study (Table 4-2). The 
investigational product and control beverages were well-tolerated by subjects with no 
adverse events reported during the duration of the study (six weeks total).  
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Table 4-2. Participant baseline characteristics: age, body mass, body mass index (BMI), 
systolic blood pressure (SBP), diastolic blood pressure (DBP), resting heart rate (HR), 
blood glucose. 
 
 Men Women Combined 
n 8 4 12 
Age (years) 37 (18-55) 35 (18-45) 37 
Body mass (kg) 79.6 (68.5-100) 74.1 (58.2-99.4) 77.8 
BMI (kg/m2) 25.0 (21.8-29.7) 26.8 (23.3-33.2) 25.6 
SBP (mmHg) 117 (107-136) 111 (104-114) 115 
DBP (mmHg) 77 (67-90) 70 (66-74) 75 
Resting HR (bpm) 58 (40-76) 63 (53-72) 60 
Blood glucose (mg/dL) 92 (86-103) 82 (75-86) 89 
 
Average weekly flavonoid consumption 
Average intakes of all individual flavonoid compounds are reported in Appendix 
B, Table B-1. The estimated total consumption of the five classes of flavonoids is 
reported in Table 4-3. The pre-study FFQ estimated that the participants’ average weekly 
consumption of total flavonoids was 635 ± 195 mg, with the highest subgroups being 
flavan-3-ols, flavonols, and anthocyanidins. The average weekly intake of dietary 
flavonoids of US adults aged 19+ years estimated from the NHANES 2007-2010 data 
reported by Kim et al., is also included in Table 4-3 [36]. After adjustments for multiple 
comparisons, flavan-3-ol and total flavonoid intake were significantly lower than those 
from the NHANES dataset (p < 0.05). 
 
Table 4-3. Average weekly consumption of flavonoids.  
 
Flavonoid Class Mean ± SEM (mg) Range (mg) US Adult Average (mg)  
Flavonols 136.5 ± 21.9 35.3 – 266.3 111.3 ± 2.8 
Flavones 11.9 ± 2.5 3.6 – 29.4 8.4 ± 0.7 
Flavanones 80.5 ± 14.7 4.6 – 193.0 85.4 ± 3.5 
Flavan-3-ols 296.3 ± 169.3* 5.5 – 2031.2 1108.8 ± 59.5 
Anthocyanidins 109.6 ± 35.4  8.0 – 452.6 80.5 ± 4.9 
TOTAL 634.7 ± 194.6* 98.1 – 2321.9 1400.7 ± 62.3 
*Significantly different from US Average [36] at p < 0.05.  
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Fecal calprotectin 
No significant difference between the treatments was observed in fecal 
calprotectin (p > 0.05). Mean fecal calprotectin for both conditions was below the assay 
detection limit of 16 μg/g.  
Fecal SCFA 
There was no significant difference between HFB and LFB for individual or total 
SCFA (Table 4-4). The most abundant fecal SCFA were acetate, propionate, and 
butyrate, present in a ratio of ~3:1:1, respectively. The total SCFA on the HFB and LFB 
were 115.1 ± 11.3 mM/g and 107.9 ± 9.7 mM/g, respectively.  
 
Table 4-4. Individual and total SCFA composition of fecal samples (mM/g wet fecal 
content), n = 12. 
Values expressed are means ± SEM. *FDR-adjusted p-value. 
 
Intestinal microbiota composition 
The average number of reads per sample was 82,944. After normalization 
(rarefying to the minimum library size and total sum scaling), the rarefaction curves 
showed adequate sequencing depth for all samples (Appendix B, Figure B-2). In total, 18 
phyla were detected in the samples, with five phyla above one percent relative 
abundance: Firmicutes (81%), Bacteroidetes (10%), Actinobacteria (4.6%), Tenericutes 
SCFA (mM/g) HFB LFB HFB-LFB p-value* 
Acetic acid 63.3 ± 6.4 59.2 ± 6.5 4.1 ± 6.7  0.8789 
Propionic acid 21.1 ± 2.2 20.7 ± 2.3 0.4 ± 2.3 0.8789 
Butyric acid 21.9 ± 3.3 19.5 ± 2.1 2.4 ± 3.4 0.8789 
Isobutyric acid 2.3 ± 0.3 2.2 ± 0.4 0.1 ± 0.3 0.8789 
Valeric acid 2.6 ± 0.3 2.6 ± 0.3 0.1 ± 0.3 0.8789 
Isovaleric acid 3.1 ± 0.4 3.0 ± 0.6 0.1 ± 0.4 0.8789 
Caproic acid 0.8 ± 0.3 0.7 ± 0.2 0.1 ± 0.4 0.8789 
TOTAL 115.1 ± 11.3 107.9 ± 9.7 7.2 ± 12.4 0.8789 
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(2.4%), Verrucomicrobia (1.3%). No significant differences were observed between HFB 
and LFB for the relative abundance at the phylum level (Table 4-5). Likewise, the 
relative abundance of Firmicutes to Bacteroidetes was not significantly different between 
conditions (Appendix B, Tables B-5 and B-6).  
Significant differences were found for two taxa: c_gammaproteobacteria (p = 
0.029) and g_Eubacterium_ruminantium_group (p = 0.025) (Table 4-6). Higher 
abundance of Eubacterium ruminantium was observed with LFB whereas higher 
abundance of Gammaproteobacteria was observed in HFB samples. No differences were 
observed at the order, family, or species levels. Over 200 groups were detected at the 
genus level, and six potentially beneficial microorganisms (Bacteroides, 
Faecalibacterium, Bifidobacterium, Roseburia, Akkermansia, Prevotella) that have been 
reported to change with flavonoid intake were further examined with post-hoc within-
subject tests, but no significant effects on relative abundance were observed (Table 4-7). 
No significant treatment differences in Chao1, Observed, and Shannon metrics of 
alpha diversity were observed at any taxonomic level (Figure 4-2).  
Within-subject comparisons based on unweighted UniFrac distance showed that 
there were no significant differences in beta diversity between the HFB and LFB samples 
(Appendix B, Table B-10). Unweighted UniFrac distances were visualized with PCoA to 
show the distance between samples in three-dimensional space. PCoA plots showed no 
clear separation between treatment groups (Figure 4-3A), and samples from each 






Table 4-5. Five most abundant phyla detected in samples (relative abundance).  
 
Phylum HFB (%) LFB (%) HFB-LFB 
Firmicutes 78.61 ± 3.64 82.92 ± 2.69 -4.31 ± 3.30 
Bacteroidetes 10.99 ± 2.64 9.83 ± 2.26 1.16 ± 2.44 
Actinobacteria 5.78 ± 1.68 3.49 ± 0.84 2.29 ± 1.53 
Tenericutes 2.79 ± 1.60 1.99 ± 1.60 0.80 ± 1.80 
Verrucomicrobia 1.22 ± 0.93 1.43 ± 0.80 -0.21 ± 0.64 
No significant differences with DESeq2 analysis. 
 
 
Table 4-6. Relative percent abundance of significantly different features. 
 
Taxa HFB (%) LFB (%) HFB-LFB p-value* 








Differential analysis with DESeq2 algorithm. *FDR-adjusted p-value. 
 
 
Table 4-7. Relative abundance of six taxa of interest. 
 
Genus HFB (%) LFB (%) HFB-LFB 
Bacteroides 6.87 ± 2.08 5.69 ± 1.74 1.18 ± 1.87 
Faecalibacterium 4.42 ± 1.18 3.51 ± 0.88 0.91 ± 1.26 
Bifidobacterium 4.93 ± 1.58 2.70 ± 0.80 2.23 ± 1.46 
Roseburia 1.82 ± 0.65 1.13 ± 0.34 0.69 ± 0.65 
Akkermansia 1.22 ± 0.93 1.43 ± 0.80 -0.21 ± 0.64 
Prevotella 0.20 ± 0.13 1.73 ± 1.07 -1.52 ± 1.07 

















Figure 4-2. Alpha diversity indices at the family level for (A) Chao1, (B) Observed 
species, and (C) Shannon. 
 
(A)       (B) 













Figure 4-3. Principal coordinate analysis (PCoA) visualization of unweighted UniFrac 
distance colored by (A) treatment and (B) subject. Axes represent the percentage of 










In the present study, we observed no effect of sub-chronic, moderate (~490 
mg/day) supplemental flavonoid intake on measures of intestinal health in a randomized 
controlled crossover trial with twelve healthy recreational cyclists. Surprisingly, daily 
consumption of a mixture of blueberry, cocoa, and green tea flavonoids did not result in 
significant differences in fecal SCFA, gut microbiota profile, or intestinal inflammation 
as compared to a low flavonoid control. The research participants were free from chronic 
disease and intestinal disorders, as was required by the study inclusion criteria. 
Participants were recreational cyclists of differing levels of experience and fitness, 
exercising at minimum three hours weekly. Though fecal calprotectin (a common 
biomarker of inflammatory intestinal pathologies) may not display measurable 
differences in the absence of disease, we expected to see an effect of the intervention on 
microbial composition and metabolism (SCFA content) due to the adaptable and 
responsive nature of the intestinal ecosystem to dietary intake [8].  
Although individual flavonoid consumption is highly variable, the average US 
adult consumes an estimated 200-250 mg total flavonoids daily [37]. Overall, our 
subjects’ estimated average intake of flavonoids reflected that of the US population for 
four of five classes of flavonoids. The estimated weekly intake of flavan-3-ols for our 
study participants (296 ± 169 mg) spanned a large range (6-2031 mg/week), and was 
significantly lower than that of the average American (1108 ± 60 mg) [36]. A significant 
dietary source of flavan-3-ols is brewed tea, and only three of twelve participants 
reported any amount of tea consumption, which may explain the difference from the 
NHANES dataset [36,37]. Due to this difference in flavan-3-ol intake, estimated total 
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flavonoid intake (635 ± 195 mg/week) was also significantly lower than that of the 
average American (1401 ± 62 mg/week).  
Our subjects’ estimated daily intake of total flavonoids was approximately 91 
mg/day, ranging from ~14-332 mg/day among subjects. The HFB provided 
approximately 490 mg/day of anthocyanins and flavan-3-ols, an increase in flavonoid 
intake of ~1.5-35 times. If the subjects’ dietary intake were closer to that of the NHANES 
data (200 mg/day), this would be an increase of about 2.5 times. The NHANES data was 
collected through 24-hour dietary recalls, administered by a trained interviewer. Although 
informative and convenient, the FFQ is a subjective assessment that is generally limited 
by the subjects’ accuracy (e.g., correctly estimating serving sizes) and recall bias [38]. 
Additionally, the FFQ adapted for this study was developed by Somerset and Papier to be 
representative of the major flavonoid dietary sources in the Australian diet [28]. Though 
both Australian and American diets fall within the Western dietary pattern, this may have 
also contributed to the differences observed between the estimated mean intakes from this 
study and the NHANES data. The limitations inherent in these dietary assessments are a 
challenge for accurately determining the influence of diet on the intestinal microbiota 
[39]. Other studies evaluating the effects of flavonoid intake on intestinal microbiota 
have used flavonoid doses ranging from 494-750 mg, but did not provide an estimate of 
subjects’ habitual flavonoid intake [13,14,20,21]. 
Overall fecal SCFA (HFB and LFB samples combined) were compared to those 
from participants of the Polyphenol Study (previously described in Chapter II, Section 
3.3)—both analyses were conducted with the same methodology in the Ward lab at USU. 
Interestingly, SCFA levels from the present study were comparable to samples collected 
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from subjects during the low flavonoid intervention and significantly higher than those 
from the high flavonoid intervention of the Polyphenol Study (Appendix B, Table B-11). 
In the Polyphenol Study, the high flavonoid dietary intervention reduced total and 
individual SCFA recovered in the fecal content compared to the control, whereas in the 
present study, there were no differences between the treatment and control. Another study 
also reported no changes in SCFA following four weeks’ consumption of apple fiber 
juice (7.5 g fiber), boysenberry polyphenol juice (750 mg polyphenols), or the 
combination thereof [20]. Dietary fiber is fermented by the colonic microflora to produce 
straight chain fatty acids while branched chain amino acids are typically metabolized into 
branched chain fatty acids. In states of gut dysbiosis, straight chain fatty acids often are 
reduced while branched chain fatty acids are elevated. While SCFA are generally 
believed to be beneficial to health, the significance of fecal SCFA content and whether 
changes in SCFA content are a cause or effect are still unclear. For example, a positive 
association was observed with fecal SCFA excretion, measures of gut dysbiosis, and 
cardiometabolic disease risk in a recent observational study of 441 adults [40]. On the 
other hand, exercise has been observed to increase SCFA excretion in lean but not obese 
individuals, and another study reported higher SCFA excretion in elite professional 
athletes compared to healthy controls [41,42]. Though determining the effect of exercise 
on intestinal microbiota and metabolism (SCFA) was not within the scope of this study, 
the potential effects of regular exercise training on microbial metabolism may have 
played a part in the subjects’ lack of response to the intervention. A limitation of the 
study is that fecal SCFA excretion may not be representative of colonic production, as 
SCFA are absorbed and utilized by epithelial cells and other tissues, and absorption 
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depends on factors such as the expression of SCFA transporters and intestinal transit time 
[40]. As a result, an additional measurement of circulating SCFA may help in future 
studies to determine SCFA production, absorption, and excretion.  
The gut microbiota varies considerably from one individual to another—microbial 
alpha diversity and SCFA content has been shown to vary with age, leanness, and 
exercise status [41–43]. Alpha diversity is a measure of the microbial diversity in a 
sample, which can be represented with species richness (i.e., the number of unique 
features in the sample) and/or evenness (i.e., distribution) [34]. Chao1 and observed alpha 
diversity are metrics of species richness, and the Shannon diversity index takes into 
account the evenness of species in addition to the overall number [34]. In the present 
study, supplemental flavonoid intake did not affect species richness or evenness relative 
to the control. Beta diversity compares the microbial community structure between 
multiple samples [44]. In particular, UniFrac is a metric used to represent the proportion 
of shared phylogenetic branches between samples, in which more similar communities 
have UniFrac scores closer to zero, while more divergent or independent samples have 
scores closer to one [44]. Within-subject comparisons of the two study conditions on 
UniFrac distance showed that there was not a differential effect of the study intervention 
on the relatively stable microbiome of each individual. These results were supported by 
the PCoA plots of beta diversity—samples tended to cluster by subject, regardless of 
treatment. Other studies have reported similar findings (minimal changes in intestinal 
microbiota following a dietary intervention), especially in shorter duration trials [22,45–
47]. So, while microbiota compositional shifts due to diet have been reported to occur in 
as little as one day, an individual’s microbiome profile is relatively stable over time and 
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likely shaped by a multitude of factors, including habitual dietary intake [48]. In a cross-
sectional study, Wu et al. reported that an individual’s overall microbiome profile had a 
greater association with long-term dietary patterns than short-term dietary changes [48]. 
In addition, a ten-day controlled-feeding study showed that despite producing measurable 
changes in microbial composition, the dietary intervention did not overcome inter-
individual variation in beta diversity [48].  
The gut microbiome is a key factor in the bioavailability and transformation of 
dietary flavonoids, so it is not surprising that flavonoid intake may have varied effects 
among individuals depending on their microbial community composition [49,50]. In 
some studies, a polyphenol or flavonoid treatment was shown to differentially affect sub-
groups of participants. For example, six-week supplementation of freeze-dried blueberry 
powder (~392 mg anthocyanins) resulted in a trend of increased alpha diversity in older 
women (age: 65-77 years, n = 6) but not in younger women (age: 21-39, n = 11) [51]. 
Another study in overweight and obese adults found that 12-week supplementation with 
epigallocatechin-3-gallate and resveratrol impacted gut microbiota composition in men 
but not women [52]. Among the male participants, supplementation tended to reduce 
Faecalibacterium prausnitzii and significantly lowered Bacteroidetes, and increased post-
prandial fat oxidation was significantly correlated to baseline Bacteroidetes abundance 
[52].  
Interestingly, independent of factors such as age, sex, ethnicity, and general 
health, the human gut microbiome appears to naturally cluster in a few distinct patterns, 
or enterotypes, rather than on a continuous spectrum [53]. The existence of different 
enterotypes or metabotypes (nutrient-metabolizing phenotypes) may explain why human 
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clinical data has been inconclusive despite strong preclinical evidence; in some studies, 
the sample size may have been insufficient to overcome natural inter-individual variation 
among subjects. In fact, the potential effects of different gut microbiota metabotypes 
stratifying the human response to polyphenol supplementation has been previously 
demonstrated and is an on-going interest in polyphenol research [54–57]. 
In a study evaluating four weeks of pomegranate juice intake, no differences were 
observed in the microbiota composition from baseline to post-intervention, but the 
authors reported a correlation of specific intestinal microorganisms with changes in fecal 
phenolic metabolites [22]. The intestinal microbiota has a large functional metabolic 
capability to metabolize a variety of substrates and generate a variety of products [7]. 
Potentially, a beneficial change in host phenotype, as a result of the metabolism of the 
intestinal microbiome, may occur without requiring significant concomitant change in 
microbiota composition—especially in an adult with a stable and diverse microbiome. It 
may only be a matter of providing the right substrates in adequate amounts to observe 
health benefits, though this would likely require a much longer period (weeks to months) 
to see measurable changes in host phenotype [39]. 
Overall, our subjects had low levels of fecal calprotectin (< 16 μg/g), suggesting 
that they had very low intestinal inflammation regardless of the treatment. Mean fecal 
calprotectin was well below clinical levels—values lower than 50 μg/g are considered 
normal, and abnormal levels are 120 μg/g or higher, which are most often observed with 
serious intestinal conditions such as inflammatory bowel disease, Crohn’s disease, and 
ulcerative colitis [58]. The flavonoid pre-workout drink did not appear to have an effect 
with subjects displaying low intestinal inflammation, which may be a reason why the 
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results from this study differed from previous work. In cases of low inflammation, a 
recent meta-analysis found that green tea supplementation did not have a significant 
effect on the inflammatory marker serum C-reactive protein (CRP) [59]. An important 
consideration when comparing findings from different studies is the study population and 
whether subjects have pre-existing conditions or are otherwise generally healthy. In many 
animal models, intestinal conditions or other pathologies are often the result of genetic 
modification, chemical induction, a selective diet (e.g., high fat), or some combination 
thereof. Approximately half of the clinical trials investigating the effects of polyphenol 
intake have been conducted in healthy subjects versus those with risk factors or disease 
[57]. In addition, another characteristic of our study population is that they were active 
and trained regularly. Exercise has been reported to have a positive effect on alpha 
diversity and the intestinal microbiota, and a six-week cycling protocol was found to 
increase Akkermansia abundance in a group of overweight women [60,61]. Elevated 
levels of the commensal microorganisms Akkermansia, Lactobacillus, and 
Bifidobacterium have been found in multiple observational studies to be associated with 
regular exercise [62].  
Another reason why the observed results may have differed from previous studies 
is due to the amount of control over potentially confounding factors. Preclinical models 
are conducted in genetically identical animals, and experiments can be controlled for 
environmental, dietary, and other study conditions. For dietary intake, clinical studies can 
vary widely—from a controlled diet to a partially restricted diet to general diet 
counseling. Other clinical studies may be conducted in controlled settings, such as a 
hospital or nursing facility. The form of the dietary intervention (whether a supplement, 
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extract, or whole food) is also expected to have an effect; bioavailability of flavonoids 
differ depending on the food matrix as well as processing conditions [63]. In the 
Polyphenol Study as well as others evaluating dietary polyphenols intake, all study meals 
were provided for the treatment and control arms, reducing the potential variation 
introduced by diet-related factors [64,65]. An effective minimum dose, whether in 
supplement, extract, or whole foods, has yet to be established for flavonoids. Effective 
doses of dietary flavonoids versus those from a supplement or extract will likely differ. 
Higher fruit, vegetable, cocoa, coffee, and tea consumption will result in higher habitual 
polyphenol intake [66]. Whether or not additional flavonoid intake will have an effect in 
combination with a background diet high in dietary flavonoids is also unknown. Most 
clinical trials, including the present study, restrict high polyphenol foods and supplements 
during the course of the study. A few studies have evaluated the effect of supplemental 
flavonoid intake without imposing diet restrictions, and in one study, positive flavonoid-
mediated effects were still observed [22,67].  
A limitation of the present study which was mentioned earlier is the sample size. 
The analyses presented here were conducted in conjunction with the study as described in 
Chapter III, which was statistically powered for the primary endpoints of intestinal 
permeability and injury. While the appropriate within-subject comparisons were 
conducted, a larger sample size may have been necessary to detect significant changes in 
intestinal microbiota, given the large inter-individual variation known to exist [39]. This 
variability demonstrates the value of a crossover design for microbiome-related studies, 
and a strength of this study is the randomized, controlled, crossover design allowing for 
within-subject comparison.  
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In conclusion, we investigated the effects of a high flavonoid supplement 
containing blueberry, green tea, and cocoa in a randomized, controlled clinical trial. The 
purpose for conducting fecal SCFA, intestinal microbiome, and fecal calprotectin 
analyses was to determine the localized effects of supplemental flavonoid intake on 
intestinal health. We found no differences in a group of twelve generally healthy, amateur 
cyclists. We did not observe consistent changes among subjects or a significant change 
within a subject, but our results are consistent with previous work suggesting that short-
term supplementation does not overcome inter-individual variation. Instead, long-term 
dietary habits appear to have the greatest impact on the microbial community. Our 
understanding of the interaction between the gut microbiota and human health is still 
lacking, and this relationship may even differ from one individual to the next. It is 
important to determine how flavonoid and polyphenol intake can affect gut health, which 
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FLAVONOID SUPPLEMENTATION AND PLASMA METABOLOMICS 
Introduction 
 Metabolomics is a comprehensive analysis used to identify and quantify all 
detectable small cellular metabolites (substrates, intermediates, products) present in a 
biological system, providing a high-resolution snapshot of the active biochemical 
processes at a given point in time [1,2]. Compared to the traditional use of individual 
biomarkers, metabolomics analyses are thought to better capture the biological impact of 
genetic or environmental changes, such as with disease, physical exercise, or a nutritional 
intervention [3]. Initially, metabolomics analyses were “targeted”, involving the 
quantitation of specific molecules of interest using either an internal or external standard 
[2]. In the last decade, rapid technological advances in high-throughput methods, 
instrument sensitivity, and data processing have enabled the development of “untargeted” 
metabolomics to detect all compounds present in a sample—potentially hundreds or 
thousands of molecules in a single analysis [2]. 
 In general, the three most commonly used analytical platforms for metabolomics 
are gas chromatography-mass spectrometry (GC-MS), liquid chromatography-MS (LC-
MS), and nuclear magnetic resonance (NMR) spectroscopy [4]. Of these, MS techniques 
are more sensitive and more frequently employed than NMR [5,6]. In comparison to LC-
MS, GC-MS has a greater number of standardized protocols, open-access availability to 
mass spectral deconvolution software, and a larger catalogue of published retention 
indices and reference spectra for compound identification. Thus, GC-MS-based 
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techniques are well-suited for resolving co-eluting compounds in complicated biological 
samples and continues to be the gold standard for metabolomics [2]. The drawback of 
GC-based metabolomics analyses is that it requires that analytes are volatile—meaning 
that samples containing non-volatile compounds (including the primary metabolites 
found in human plasma) require chemical derivatization prior to analysis [2]. Fortunately, 
many options for derivatization are available, and trimethylsilylation, the most commonly 
used method, can be performed under mild conditions with relatively high yield [5]. This 
derivatization replaces the acidic proton in carboxylic acids, amines, thiols, and 
hydroxides with a trimethylsilyl (TMS) group, and following derivatization, GC-MS 
analysis can detect a wide range of metabolites including sugars, amino acids, lipids, 
alcohols, catecholamines, and xenobiotics [2,5]. Generally, GC-MS is preferable for the 
separation and identification of sugars and hydroxyl acids, but for larger metabolites, 
including flavonoids and complex lipids, LC-MS methods are better suited for analysis 
[2]. As a result, these complementary methods are ideally utilized together to obtain 
greater coverage in metabolomics analyses [2]. 
 Alongside advances in the capabilities of metabolomics profiling, research groups 
have begun to explore the effects of exercise on the human metabolome [1,6]. Large 
shifts in over 200 metabolites have been observed with exercise, particularly with longer 
duration and higher intensity exercise [1,3]. During exercise, cellular metabolism ramps 
up to supply up to ten times more adenosine triphosphate (ATP) than at rest to meet 
increased workload demands [6]. Depending on substrate availability, this involves the 
mobilization and utilization of glycogen, triglyceride, and amino acid stores [6]. Studies 
have consistently reported significant changes in lipids (e.g., plasma medium and long 
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chain fatty acids, fatty acid oxidation products, ketone bodies, and triglycerides), amino 
acids, bile acids, and tricarboxylic acid cycle intermediates with exercise [1,6]. 
An ongoing interest in sports nutrition research is in dietary supplements that 
complement and support exercise performance and recovery. Among these dietary 
supplements of interest are fruit-derived flavonoids for their potential ergogenic effects 
(for further discussion, see Chapter II, Section 3.4) [7]. Flavonoids are a diverse class of 
plant secondary metabolites, and the number of research publications involving these 
phytochemicals has increased rapidly in the last two decades [8]. This is due in part to the 
observation that diets abundant in flavonoid-containing fruits and vegetables have 
consistently been associated with a reduced risk of cardiometabolic disease and overall 
mortality [9–12]. The molecular basis for these effects was initially attributed to the high 
free-radical scavenging activity of flavonoids in vitro [13]. However, polyphenols (a 
class of phytochemicals of which flavonoids are the largest subgroup) are highly 
metabolized through a coordinated effort by both host and microbiota [14]. In general, 
with the exception of flavan-3-ols, native flavonoids are glycated, which results in low 
absorption in the small intestine and increases flavonoids exposed to the colonic 
microflora [15]. Except in the proximal intestinal tract where native polyphenols may 
reach high enough concentrations to potentially act as radical scavengers, the current 
consensus is that dietary flavonoids are not acting as direct antioxidants in vivo [13]. 
Instead, a single compound can be transformed into an array of different metabolites, and 
these metabolites are considered to be the main bioactive agents driving the physiological 
effects observed as a result of flavonoid consumption, and may even display greater 
bioactivity than their precursor parent compounds [7,16–18]. In a cell culture model, 
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various flavonoid metabolites (protocatechuic acid, 4-hydroxybenzoic acid, vanillic acid, 
benzoic acid-glucuronide, benzoic acid-sulfate, protocatechuic acid-3-glucuronide) were 
shown to reduce LPS-induced TNF-α production to a greater extent than their precursor 
flavonoids [18].  
Microbiome-mediated effects have been found to be highly variable among 
individuals, likely due to the large microbial diversity from person to person [13]. 
However, the human intestinal microbiome is also characterized by functional 
redundancy, where different members can fill the same function (e.g., butyrate 
production) within the microbial community [19]. Characterization of the functional 
“metabolome” produced by the microbiome may be more important than the effects of 
inter-individual variation in microbiome diversity and abundance. Metabolomics analysis 
over a series of time points may allow better understanding of the dynamic changes 
occurring as a result of a nutritional intervention. Significant changes in microbiome-
derived phenolic compounds have been detected in circulation following flavonoid 
intake. Several studies conducted by Nieman et al. have explored the effects of fruit and 
fruit-derived flavonoid consumption on the exercise metabolome [1,7,20–23]. In one that 
study utilized both ultrahigh performance LC-tandem MS (UHPLC-MS/MS) and GC-
MS, elevated serum levels of the gut phenolic metabolites hippurate and 4-
methylcatechol sulfate were detected after a 3-day intensive exercise workload with 17-
day blueberry and green tea intake (equivalent to 3 cups of fresh blueberries and 1.3 cups 
of brewed green tea) [20]. However, no differences in oxidative stress or inflammation 
were observed between the polyphenol treatment and control [20]. In a 75-km cycling 
trial comparing banana consumption versus a 6% carbohydrate drink, GC-MS-based 
140 
metabolomics analysis showed that 56 out of 103 metabolites changed significantly with 
exercise, and only one metabolite (dopamine) was different between the banana treatment 
and carbohydrate control [21]. In another study comparing banana, pear, and a water 
control, cycling time improved 5.0% and 3.3% on the banana and pear treatments, 
respectively [22]. Banana and pear intake improved perceptual measures of performance 
(energy, focus, and overall well-being) and reduced post-exercise measures of 
inflammation (IL-10, cortisol, total leukocytes) [22]. Furthermore, UHPLC-MS/MS-
based metabolomics showed that banana and pear ingestion elevated carbohydrate, fruit-
specific, and phenolic compounds, while attenuating the exercise-induced metabolite 
response in lipid mobilization and oxidation pathways [22]. In a follow-up study, two 
different varieties of banana (Cavendish and mini-yellow) were compared with a 6% 
carbohydrate drink and water during a 75-km cycling trial [23]. (Mini-yellow bananas 
have a similar carbohydrate profile but 63% higher polyphenol content than Cavendish 
bananas [23].) Both banana treatments resulted in significant UHPLC-MS/MS-detected 
metabolite differences in amino acid and xenobiotic pathways from the water and 
carbohydrate controls; the water-only trial also resulted in a significantly greater exercise 
perturbation in the metabolite profile as compared to the carbohydrate and banana trials 
[23].  
Fruit-derived polyphenols appear to have a beneficial effect on exercise 
performance and recovery, and metabolomics studies have shown potential in 
determining phenolic and other metabolite responses to flavonoid intake [3,7]. While 
some exercise studies have incorporated metabolomics analyses, more work is still 
needed to better understand the interaction between flavonoid consumption and the 
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exercise metabolome [3]. A few different modes of exercise have been employed 
(cycling, running, swimming) with different supplementation schemes (acute and 
chronic), ranging from “whole food” interventions to purified polyphenols [3]. In the 
present study, we investigated changes in plasma metabolites following 15-day 
consumption of either a high- or low-flavonoid pre-workout beverage (HFB and LFB, 
respectively) in plasma samples from the randomized, controlled crossover trial described 
in Chapter III. Plasma samples were collected before exercise, following exercise, and 
during the subsequent recovery period to determine metabolite shifts over time with 
either treatment. The purpose of this study was to conduct an untargeted GC-MS-based 
metabolomics analysis to investigate the effect of flavonoid ingestion on the plasma 
metabolome, in order to better direct future recommendations for exercise nutrition. We 
hypothesized that flavonoid metabolites would be detected in the plasma following HFB 
consumption, and that plasma metabolites associated with exercise (e.g., glucose, lactate, 
energy metabolism intermediates, and lipids) would demonstrate the greatest extent of 
change from baseline to immediately post-exercise. 
 
Materials and Methods 
Research design 
 This study was conducted as a part of the randomized clinical trial as described 
previously in Chapter III. The study was approved by the USU institutional review board 
(IRB Protocol #9255). Participants were informed of all study requirements and provided 
written informed consent prior to enrollment. A complete list of inclusion and exclusion 
criteria is provided in Appendix A, Table A-1. 
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In brief, twelve cyclists completed this crossover study with two fifteen-day 
treatment arms separated by a two-week washout period. During the intervention, 
subjects consumed a pre-workout beverage containing blueberry, cocoa, and green tea 
flavonoids (~490 mg total flavonoids) or a low flavonoid control (< 5 mg flavonoids) 
daily. On Day 14, participants recorded their evening meal in a provided food journal and 
continued recording all foods and beverages consumed through the end of the final 
sample collection the following day. Participants were instructed to replicate all food and 
beverage intake for the second intervention. Additionally, participants were instructed to 
abstain from alcohol and strenuous activity on Day 14. On Day 15, research participants 
completed a 1-hour cycling trial (45-min at 70% VO2max + 15-min TT) and provided 
four blood samples: pre-exercise, post-exercise, 1-h post-exercise, and 4-h post exercise 
(Figure 5-1). Seated venous blood samples were collected via antecubital venipuncture in 
potassium ethylenediaminetetraacetic acid (K2EDTA)-treated Vacutainer tubes and 
centrifuged (1500 × g, 10 min, 4 °C). Plasma was aliquoted to 1.5-ml polypropylene 
microcentrifuge tubes and stored frozen at -80 °C until further analysis. 
 
Figure 5-1. Schematic of study design and endpoint collection. HFB = high flavonoid 







 The pre-workout supplement was designed to provide for the metabolic demands 
of high intensity endurance exercise [24,25]. A general recommendation for endurance 
exercise is 1-2 g carbohydrate (CHO) and 0.15-0.25 g protein (PRO) per kilogram of 
body weight consumed prior to activity [26]. The macronutrient composition of fluid 
bovine milk is particularly well-suited for this purpose, and dairy-derived protein is ideal 
for sports nutrition due to its ease of digestion and absorption, branched chain amino acid 
content, and protein quality [27]. As a result, the investigational product—prepared from 
blueberry, cocoa, and green tea powders and 2% milk—is formulated to supply 66 g 
CHO and 9 g PRO per serving. 
 One serving of the high flavonoid beverage (HFB) provided approximately 490 
mg total flavonoids, while the low flavonoid beverage (LFB) contained approximately 
4.6 mg flavonoids due to three modifications: alkalized cocoa, blueberry placebo powder, 
and the omission of green tea powder. The green tea extract contained approximately 800 
mg/g tea catechins (PureBulk, Inc; Roseburg, Oregon). High flavonoid cocoa powder (83 
mg/g cocoa flavanols) and alkalized cocoa (10 mg/g flavanols) were provided by Barry 
Callebaut (Zurich, Switzerland). Freeze-dried blueberry powder (14.0 mg/g total 
anthocyanins) and blueberry placebo powder were supplied by the US Highbush 
Blueberry Council (Folsom, California). 
Plasma metabolomics 
 Methods for sample extraction and derivatization for gas chromatography-mass 
spectrometry (GC-MS) metabolomics profiling were adapted from Fiehn [2]. Sample 
extractions were prepared in duplicate. A method and derivatization blank was prepared 
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alongside the samples, but without the addition of plasma. For sample cleanup and 
extraction, 30 µL of plasma was mixed with 10 µL of 200 ppm ribitol (internal standard) 
and 1 mL of an acetonitrile, isopropanol, and water mixture (3:3:2, v/v/v) at -20C. The 
mixture was shaken for 5 min, centrifuged at 14,000 relative centrifugal force (RCF) for 
2 minutes. Next, 450 µL of supernatant was removed to a fresh container and evaporated 
to dryness in a centrifugal vacuum evaporator. The dried aliquot was re-suspended in 450 
µL nitrogen-degassed acetonitrile/water (1:1, v/v), thoroughly mixed, and centrifuged at 
14,000 RCF for 2 minutes. The supernatant was removed, evaporated to dryness, and 
stored at -20C.  
A reagent blank was prepared alongside the samples (without the addition of 
plasma) beginning from this point forward. Additionally, a quality control mixture of 25 
sugars, amino acids, lipids, and other metabolites was prepared as well (Appendix C). 
Samples were derivatized with 20 µL methoxyamine hydrochloride in pyridine (20 
mg/ml). Following the addition of methoxyamine, samples were shaken for 1.5 hours. 
Next, 80 µL of a mixture of N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) 
and fatty acid methyl esters (FAME) were added to each sample. Samples were then 
shaken for another 30 min and then submitted to GC-MS analysis.  
The GC-MS platform was a Shimadzu single quadrupole gas chromatograph mass 
spectrometer (GCMS-QP2010 SE) with a Zebron ZB-5MSi plus (30 m × 0.25 mm 
diameter × 0.25 μm film thickness) capillary GC column (Phenomenex, Torrance, CA, 
USA). Helium was used as the carrier gas, and the column flow rate was 1.18 ml/min, 
with splitless injection and 5.5 min solvent cut time. The temperatures of the inlet, ion 
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source, and transfer line were 250 °C, 230 °C, and 290 °C, respectively. The column 
oven temperature program used for compound separation is shown in Table 5-1.  
 
Table 5-1. GC oven temperature program for plasma metabolomics. 
 
Rate (°C/min) Temperature (°C) Hold Time (min) 
-- 60 1 
10 325 10 
 
 
Compound peaks were selected by visual comparison of the chromatograms from 
the samples and method and reagent blanks, and features unique to the plasma samples 
were selected for identification. Peaks were deconvoluted with the automatic mass 
spectral deconvolution and identification system (AMDIS), identified with mass spectral 
and FAME retention index library comparison, and confirmed with the National Institute 
of Standards and Technology (NIST) mass spectral database. A quality control (QC) 
standard mixture of selected sugars, amino acids, lipids, and other small metabolites was 
also used for identification of these compounds. Peak areas were determined, and 
multiple peaks representing the same compound—isomers and those formed from 
incomplete TMS derivatization—were grouped into single features. Compounds 
determined to be artifacts (e.g., polysiloxanes from moisture introduced during 
derivatization, phthalates from plastics, derivatization reagent by-products, and EDTA 
from the collection tubes) and FAME were omitted from the final compound table.  
Statistical analysis 
 The final peak intensities table was uploaded to MetaboAnalyst 5.0 and analyses 
were completed using the online platform [28]. Missing values were assumed to be below 
the limit of detection and were imputed with 1/5 of the compound minimum value. 
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Compound peak areas were normalized by the ribitol internal standard, log-transformed, 
and auto-scaled (mean-centered, divided by the standard deviation of each feature). A 
two-way repeated measures ANOVA was conducted to determine differences in 
normalized, scaled metabolite abundance, with the FDR adjusted q-value to take into 
account the multiple comparisons across metabolites. Statistical significance was set at q 
< 0.05. Log2-transformed within-subject fold changes immediately post-exercise, 1 h 
post-exercise, and 4 h post-exercise (relative to pre-exercise) were determined from the 
ribitol-normalized peak intensities. Post-hoc testing with Tukey’s HSD was conducted 
for metabolites with a significant main effect; post-hoc tests were performed with JMP 




 Twelve subjects (female n = 4, male n = 8; mean ± SD: age 37 ± 11 years, body 
mass 78 ± 13 kg, height 1.74 ± 0.09 m, VO2max 43 ± 6 ml/kg/min) completed both arms 
of the study. Both trials elicited a similar response in physiological and perceptual 
measures (Table 5-2). 
Physiological and perceptual responses to exercise 
 The exercise test elicited a similar change in heart rate (HR), rating of perceived 
exertion (RPE), and core temperature regardless of the treatment (Table 5-2). Expired air 
samples collected during the steady state exercise confirmed that cyclists were cycling at 
~70% VO2max. Performance measures (time trial cycling distance and cadence) were not 
significantly different between trials (Table 5-2). 
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Table 5-2. Cycling trial: physiological and perceptual measures  
 
 HFB LFB HFB-LFB 
Final core temperature (°C) 38.53 ± 0.06 38.51 ± 0.23 0.02 ± 0.20 
HRmax (bpm) 174 ± 4 175 ± 5 -1 ± 2 
RPE 4.0 ± 0.4 3.9 ± 0.5 0.08 ± 0.3 
TT distance (km) 19.3 ± 0.7 18.9 ± 0.8 0.4 ± 0.3 
Cadence (rpm) 93 ± 3 93 ± 3 0 ± 2 
HR = heart rate, bpm = beats per minute, RPE = rating of perceived exertion, TT = time 
trial, rpm = revolutions per minute. 
 
 
Untargeted plasma metabolomics 
 Several hundred features were detected in each sample, but many were 
determined to be artifacts (contaminants or extraction/derivatization reagents), 
indistinguishable from the background signal, or unidentifiable due to lack of a suitable 
library match. Manual inspection of chromatograms yielded 92 metabolites in the plasma 
samples that differed from the derivatization and reagent controls. Data cleaning involved 
condensing metabolites with multiple peaks, removing artifacts, and peak alignment of 
the compound table across all 96 samples. A total of 62 metabolites were tabulated, with 
42 identified metabolites and 20 unknown compounds. We identified eight 
carbohydrates, sixteen amino acids, twelve lipids, two cofactors and vitamins, two energy 
metabolites, and one xenobiotic. Annotated metabolites are listed in Table 5-3, along 
with their FAME retention indices (RI), retention times (RT), compound identifiers, and 
associated metabolic pathways.  
 Principle component analysis (PCA) showed that the samples grouped together 
according to time, with less distinction between treatments (Figure 5-2). The PC1, PC2, 
and PC3 axes explained 17.1%, 14.6%, and 10.2% of the total data set variance, 
respectively. There appeared to be a larger separation for the metabolome at time 5 than 
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at all other times, and a slight separation with the pre-exercise metabolome (time 0). 
Metabolites immediately post-exercise (time 1) and 1-h post exercise (time 2) appeared to 
have some separation but were grouped more closely together than other times.  
 The heatmap generated with Euclidean distance measure and Ward clustering 
algorithm is shown in Figure 5-3. Sample groups A-H and sub-groups 1-16 were 
designated based on the clusters generated. Groups and sub-group designations are also 
included in Table 5-3 along with the general classification of metabolite super and sub 
pathways. Group A metabolites include the ketone body 3-hydroxybutyrate along with 
four long chain fatty acids (14:0, 16:0, 18:1, 18:2n6); overall, these lipids were lower pre-
exercise compared to immediately post-exercise, with mixed responses at later times. 
Carbohydrates and energy metabolism-associated compounds (group B) were elevated 
immediately post-exercise and lower 1-h and 4-h post-exercise. A few different 
metabolite classes are represented in group C with relatively higher abundance 
immediately post-exercise and 1-h post-exercise for myo-inositol and citrate. Seven 
unknown compounds were grouped in D with the lipids palmitelaidic acid, α-tocopherol, 
and cholesterol with most metabolites being more abundant at times 1 and 2 compared to 
0 and 5. Interestingly, metabolites in groups E and F appear to be consistently elevated at 
time 5, 4-h post-exercise. A few different metabolite classes are represented in Group G, 
and these metabolites appear to be most abundant pre-exercise. Finally, Group H consists 
of eleven amino acids and related compounds, in addition to an unknown, carbohydrate, 
and vitamin/cofactor metabolite.  
The two-way repeated measures ANOVA (log-transformed and auto-scaled 
values) showed that 56 of 62 total features were significant with respect to time (FDR-
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adjusted q-value < 0.05) (Appendix C, Table C-1). Metabolites without significant time 
effects were aspartate, benzoate, glycolic acid, 2-hydroxy-3-methylpentanoic acid 
(HMVA), methionine, and unknown 9. No significant treatment effects or treatment by 
time interactions were observed for any of the metabolites.  
Of particular interest were select metabolites from three super pathways expected 
to change most with exercise: compounds involved in glycolysis and energy metabolism, 
lipids and ketone bodies, and amino acids. The response over time for a few selected 
compounds are shown in Figure 5-4. Since only the time effect was significant, values 
plotted are HFB and LFB combined.  
The log2-transformed mean fold changes from pre-exercise for these metabolites 
are reported in Tables 5-4 through 5-6. Increases and decreases in abundance relative to 
pre-exercise is reflected in values > 0 and < 0, respectively. Since only the main effect of 
time was significant, differences determined from post-hoc tests are indicated for overall 




















Figure 5-2. Three-dimensional PCA of untargeted metabolomics analysis colored by 












Figure 5-3. Heatmap visualization of plasma metabolites grouped by time, then treatment. Samples are arranged in columns. Darker 
red indicates higher abundance and darker blue indicates lower abundance. 
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Table 5-3. Identified plasma metabolites: retention index (RI), retention time (RT), Human Metabolome Database (HMDB) number, 
PubChem identifier, Kyoto Encyclopedia of Genes and Genomes (KEGG) identifier, super and sub pathway association. 
 








1169 8.420 HMDB0000357 441 C01089 A 1 Lipid Ketone bodies 
Linoleic acid C18:2n6 2212 20.390 HMDB0000673 5280450 C01595 A 2 Lipid Long chain fatty acids 
Oleic acid C18:1 2217 20.442 HMDB0000207 445639 C00712 A 2 Lipid Long chain fatty acids 
Myristic acid C14:0 1847 16.870 HMDB0000806 11005 C06424 A 2 Lipid Long chain fatty acids 
Palmitic acid C16:0 2044 18.850 HMDB0000220 985 C00249 A 2 Lipid Long chain fatty acids 
Unknown disaccharide 1 1983 18.259    B 3 Carbohydrate Disaccharides and oligosaccharides 
Unknown 
monosaccharide 
2058 18.977    B 3 Carbohydrate Monosaccharides 
Pyruvate 1063 6.843 HMDB0000243 1060 C00022 B 4 Carbohydrate 
Glycolysis, gluconeogenesis, pyruvate 
metabolism 
L-Lactate 1076 7.041 HMDB0000190 61503 C00186 B 4 Carbohydrate 
Glycolysis, gluconeogenesis, pyruvate 
metabolism 








HMDB0000122 5793 C00221 B 4 Carbohydrate 
Glycolysis, gluconeogenesis, pyruvate 
metabolism 
Unknown 9 1864 17.047    C 5   
L-Tyrosine 1896 17.390 HMDB0000158 6057 C00082 C 5 Amino acid Tyrosine metabolism 
Creatinine 1571 13.790 HMDB0000562 588 C00791 C 6 Amino acid 
Creatine metabolism 
Biogenic amine 
Citrate 1839 16.790 HMDB0000094 311 C00158 C 6 Energy Tricarboxylic acid cycle 
Myo-inositol 2127 19.623 HMDB0000211 - C00137 C 6 Carbohydrate Galactose metabolism 
Unknown 4 1469 12.537    D 7   
Unknown 10 2160 19.926    D 7   
Palmitelaidic acid  
trans-16:1 
3934 32.240 HMDB0012328 5282745 - D 7 Lipid Long chain fatty acids 
Unknown 16 3599 30.050    D 7   
Unknown 17 3925 32.165    D 7   
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Table 5-3 continued. Identified plasma metabolites: retention index (RI), retention time (RT), Human Metabolome Database (HMDB) 
number, PubChem identifier, Kyoto Encyclopedia of Genes and Genomes (KEGG) identifier, super and sub pathway association. 
 
Metabolite RI RT HMDB PubChem KEGG Group 
Sub-
group 
Class/Super pathway Sub pathway 
Unknown 14 2785 24.933    D 8   
Unknown 15 2820 25.191    D 8   
Unknown 11 2248 20.691    D 8   
α-tocopherol 3168 27.515 HMDB0001893 14985 C02477 D 8 Cofactors and vitamins Tocopherol metabolism 
Cholesterol 3198 27.707 HMDB0000067 5997 C00187 D 8 Lipid Sterol 
L-Isoleucine 1184 8.634 HMDB0000172 6306 C00407 E 9 Amino acid 
Leucine, isoleucine, valine metabolism; 
Glucogenic/ketogenic 
Unknown 2 1422 11.930    E 9   
Benzoate 1253 9.630 HMDB0001870 243 C00539 E 10 Xenobiotic Benzoate metabolism 
Glycolic acid 1090 7.249 HMDB0000115 757 C03547 E 10 Lipid Hydroxy fatty acid 
Unknown 7 1696 15.253    E 10   
Unknown 6 1553 13.567    F 11   
Stearic acid C18:0 2241 20.666 HMDB0000827 5281 C01530 F 11 Lipid Long chain fatty acids 
Unknown 13 2593 23.513    F 11   
Homoserine 1687 15.147 HMDB0000719 12647 C00263 F 11 Amino acid Methionine, threonine, isoleucine 
Dehydroabietic acid 2410 22.077 HMDB0061925 - - F 11 Lipid - 
Erythronate 1578 13.874 HMDB0000613 2781043 - F 12 Carbohydrate Aminosugar metabolism 





Unknown 8 1705 15.341    F 12   
Unknown 3 1433 12.028    G 13   
1,2-Propanediol 1018 6.183 HMDB0001881 1030 C02912 G 13 Carbohydrate 
Glycolysis, gluconeogenesis, pyruvate 
metabolism 
Beta-alanine 1436 12.113 HMDB0000056 239 C00099 G 13 
Nucleotide 
Amino acid 
Pyrimidine metabolism, uracil 
containing 
Unknown 1 1152 8.173    G 13   
Lauric acid C12:0 1663 14.727 HMDB0000638 3893 C02679 G 13 Lipid Free fatty acids 
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Table 5-3 continued. Identified plasma metabolites: retention index (RI), retention time (RT), Human Metabolome Database (HMDB) 
number, PubChem identifier, Kyoto Encyclopedia of Genes and Genomes (KEGG) identifier, super and sub pathway association. 
 






Unknown 12 2378 21.810    G 14   
Unknown 
disaccharide 2 
2758 24.753    G 14 Carbohydrate Disaccharides and oligosaccharides 
L-Methionine 1416 11.838 HMDB0000696 6137 C00073 G 14 Amino acid 







HMDB0000660 439709 C02336 G 14 Carbohydrate Fructose, mannose, and galactose metabolism 
Sorbitol 1874 17.166 HMDB0000247 5780 C00794 H 15 Carbohydrate Fructose, mannose, and galactose metabolism 
Glycine 1317 10.528 HMDB0000123 750 C00037 H 15 Amino acid 







HMDB0000187 5951 C00065 H 15 Amino acid 







HMDB0000167 6288 C00188 H 15 Amino acid 
Glycine, serine, threonine metabolism; 
Glucogenic/ketogenic 














HMDB0000883 6287 C00183 H 16 Amino acid 







HMDB0000687 6106 C00123 H 16 Amino acid 





1189 8.769 HMDB0000317 10796774 - H 16 
Lipid/Amino 
acid 
Hydroxy fatty acid; Product of ketogenic amino 
acid metabolism 
Urea 1247 9.515 HMDB0000294 2447 C00086 H 16 Amino acid Urea cycle; Arginine and proline metabolism 
Oxalic acid 1141 8.015 HMDB0002329 971 C00209 H 16 
Cofactors and 
vitamins 
Ascorbate and aldarate metabolism 
L-Lysine 1937 17.809 HMDB0000182 5962 C00047 H 16 Amino acid Lysine metabolism; Ketogenic 
L-Alanine 1115 7.621 HMDB0000161 5950 C00041 H 16 Amino acid Alanine and aspartate metabolism; Glucogenic 





Figure 5-4. Plasma metabolites pre- and post-exercise. Overall mean is plotted in red, 
black lines are individual subjects. Since treatment effects were not significant, overall 
means are plotted for HFB and LFB combined, at each time. Different letters indicate 
significantly different groups (Tukey’s HSD).  
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Figure 5-4 continued. Plasma metabolites pre- and post-exercise. Overall mean is plotted 
in red, black lines are individual subjects. Since treatment effects were not significant, 
overall means are plotted for HFB and LFB combined, at each time. Different letters 
indicate significantly different groups (Tukey’s HSD). 
 




Table 5-4. Fold changes from baseline (immediately, 1 hour, and 4 hours post-exercise) 
in glycolysis and energy metabolites. 
 







Post-ex 0.25 0.10 0.34 -0.24 
1 h post-ex -0.40 -0.60 -0.26 -0.34 





Post-ex 1.76 1.66 1.75 -0.08 
1 h post-ex -0.14 -0.23 -0.12 -0.11 





Post-ex 0.92 0.63 1.04 -0.41 
1 h post-ex -0.18 -0.22 -0.16 -0.06 




Post-ex 0.47 0.42 0.50 -0.08 
1 h post-ex 0.35 0.27 0.40 -0.13 
4 h post-ex 0.04 0.00 0.08 -0.08 
Data are log2-transformed values. Post-hoc testing: overall values lsmeans significant 









Table 5-5. Fold changes from baseline (immediately, 1 hour, and 4 hours post-exercise) 













Post-ex -0.61 -0.49 -0.89 0.40 
1 h post-ex -0.60 -0.50 -0.89 0.39 





Post-ex 0.72 0.76 0.55 0.20 
1 h post-ex 0.06 0.15 -0.27 0.41 





Post-ex 0.81 0.74 0.80 -0.06 
1 h post-ex 0.22 0.21 0.15 0.06 





Post-ex 0.24 0.27 -0.01 0.28 
1 h post-ex 0.23 0.22 0.17 0.05 





Post-ex 2.67 2.26 2.83 -0.57 
1 h post-ex 1.49 1.29 1.48 -0.19 





Post-ex 2.34 1.98 2.51 -0.52 
1 h post-ex 1.02 0.93 0.87 0.06 






Post-ex 1.24 1.33 1.08 0.25 
1 h post-ex 0.39 0.59 0.06 0.53 
4 h post-ex 0.99 0.83 0.96 -0.13 
α-tocopherol Vitamin 
Post-ex 0.38 0.28 0.39 -0.11 
1 h post-ex 0.47 0.38 0.48 -0.10 





Post-ex -0.21 -0.37 -0.31 -0.05 
1 h post-ex 1.95 1.73 1.99 -0.26 
4 h post-ex 2.10 1.81 2.15 -0.33 
Data are log2-transformed values. Post-hoc testing: overall values lsmeans significant 











Table 5-6. Fold changes from baseline (immediately, 1 hour, and 4 hours post-exercise) 











Post-ex -0.16 -0.22 -0.25 0.03 
1 h post-ex -1.10 -1.19 -1.11 -0.08 




Post-ex -0.07 -0.05 -0.13 0.08 
1 h post-ex -0.31 -0.25 -0.41 0.17 




Post-ex -0.31 -0.39 -0.37 -0.03 
1 h post-ex -0.48 -0.58 -0.44 -0.14 




Post-ex -0.31 -0.28 -0.37 0.09 
1 h post-ex -0.71 -0.69 -0.75 0.06 






Post-ex 0.91 0.87 0.51 0.36 
1 h post-ex 0.68 0.58 0.43 0.15 






Post-ex -0.14 -0.15 -0.16 0.01 
1 h post-ex -0.43 -0.49 -0.40 -0.09 






Post-ex 0.26 0.18 0.30 -0.12 
1 h post-ex 0.12 -0.06 0.22 -0.28 




Post-ex -0.54 -0.70 -0.46 -0.24 
1 h post-ex -1.37 -1.63 -1.34 -0.29 




Post-ex -0.34 -0.60 -0.31 -0.29 
1 h post-ex -1.09 -0.91 -1.46 0.56 
4 h post-ex 0.30 -0.28 -0.67 0.38 
Data are log2-transformed values. Post-hoc testing: overall values lsmeans significant 
differences from pre-exercise determined by Tukey’s HSD are highlighted. 
 
Discussion 
 In the present study, we investigated the plasma metabolome before and after a 




setting during which participants cycled for 45 minutes at a fixed intensity (70% 
VO2max), followed by a 15-minute time trial. Food intake beginning in the evening prior 
to the trial through the end of the recovery period was recorded by the participant and 
replicated during the second arm. Study aims were two-fold: to investigate the plasma 
metabolome pre- and post-exercise and to determine if flavonoid-derived metabolites can 
be detected from pre-workout flavonoid intake. In the discussion that follows, samples 
collected immediately (time 1), one hour (time 2), and four hours (time 5) post-exercise 
are considered early, intermediate, and late recovery phase samples, respectively [6]. 
The PCA and heatmap visualization showed metabolome differentiation with 
respect to time and not treatment, despite our hypothesis that the HFB and LFB would 
differentially impact metabolism. Metabolite profiles clustered distinctly according to 
time with the greatest separation in the late recovery phase than at any other time—
several metabolites like homoserine only appeared at time 5. This may be due to the 
longer length of time between times 2 and 5, as well as the result of lunch and snacks 
consumed during this time. In terms of food intake, the participants consumed breakfast 
and the HFB/LFB two hours prior to sampling at time 0, a standardized sugar solution 
after sampling at time 1, and lunch/snacks were allowed between times 2 and 5. 
Breakfast, lunch, and snacks were individually-determined and replicated in the second 
trial. Nonetheless, individual differences in food intake are not likely to have changed the 
overall trends observed in the plasma metabolome as a whole, since food intake does not 
impact metabolic flux to the same extent as a bout of exhaustive endurance exercise [29].  
The heatmap generated with the clustering algorithm grouped the metabolites into 




super and sub pathways, metabolites involved in similar pathways clustered together in 
the analysis. Overall, these metabolite patterns are consistent with the findings from a 
systematic review of exercise metabolomics studies: early phase post-exercise increases 
in carbohydrates and energy metabolism metabolites (lactate, pyruvate, TCA 
intermediates), a large elevation in lipids, and a mixed response in amino acids [6].  
Large fold changes were observed in lactate, pyruvate, and citric acid 
immediately following exercise. Lactate, as a product of anaerobic glycolytic 
metabolism, has historically been used as an indicator of endurance capacity at a given 
exercise intensity [30]. High levels of pyruvate, in addition to lactate, accumulate as a 
result of glycolysis and anaerobic metabolism [6]. The time course profile of lactate and 
pyruvate (elevated immediately post-exercise, followed by a decline to baseline after an 
hour of recovery), reflect the responsiveness of these metabolic pathways to the energy 
demands of exercise. Several different pathways contribute to glucose flux: 
glycogenolysis and gluconeogenesis in the liver increase glucose availability while 
glucose uptake increases in muscle tissues through insulin-independent mechanisms 
[31,32]. Following cessation of exercise, glucose uptake continues to be elevated during 
recovery, which reduces circulating glucose and may explain the reduction in plasma 
glucose observed after one hour of recovery [33]. The TCA intermediate citrate was 
elevated during the early and intermediate phases of recovery but returned to baseline 
after four hours of recovery. Other than citrate, we did not detect any other TCA cycle 
intermediates (e.g., malate, aconitate, fumarate, succinate, and α-ketoglutarate), though 




Endurance exercise elicits a strong response in circulating free fatty acids and 
ketone bodies as alternative fuel sources to glucose [6]. During prolonged moderate 
intensity exercise, lipids are mobilized for energy production, and lipid metabolism 
contributes a considerable amount to energy production through β-oxidation and ketone 
body formation [29]. Nieman et al. found that metabolites involved in lipolysis and lipid 
oxidation are strong predictors of the metabolic response to intensive endurance exercise 
[34]. Similarly, all 37 fatty acids reported in the systematic review by Schranner et al. 
increased following exercise [6]. In the present study, the greatest fold changes of all 
metabolites were observed in lipid-related compounds. In particular, long chain free fatty 
acids (palmitic, stearic, oleic, and linoleic) and the ketone body 3-hydroxybutyrate 
displayed large fold increases and sustained responses to exercise. This may demonstrate 
that lipolysis and lipid oxidation was increased as a result of exercise and continued to be 
pronounced during the late recovery phase. Prior data for responses of ketone bodies is 
somewhat mixed, but they more often appear to increase following exercise. Ketone 
bodies are synthesized from ketogenic amino acids and acetyl CoA as alternative fuel for 
the brain and muscle tissues during long-duration exercise when carbohydrates become 
limited [35]. Other lipid metabolites (triacylglycerols, dicarboxylate and monohydroxy 
fatty acids, acylcarnitines, and other ketone bodies) were not detected or identified in the 
analysis.  
The patterns and directions of change for amino acids following exercise are not 
as consistent across studies in comparison to lipids, but in general, lower amino acid 
concentrations are reported following exercise [6]. Amino acids are in constant flux 




potential and sub pathway association. As glycogen stores are depleted and β-oxidation 
pathways become saturated during prolonged exercise, glucogenic and ketogenic amino 
acids may be transformed to glucose and ketone bodies, respectively, to provide the 
necessary substrates for continued energy metabolism [6,36]. The majority of the 
detected amino acids decreased relative to baseline with the exception of isoleucine, 
which was elevated ~3.7-fold at time 5. In the heatmap visualization, most proteinogenic 
amino acids clustered together in group H while isoleucine was in group E. This is 
somewhat surprising since isoleucine is a branched chain amino acid (BCAA) along with 
leucine and valine, but the reason for the difference in response to exercise is unclear. 
Aside from isoleucine, the fold changes of the amino acids were relatively small. 
Carbohydrate intake, such as with the pre-workout HFB and LFB, will reduce the rate of 
gluconeogenesis and ketogenesis, which also reduces amino acid demand [6]. Thus, 
smaller responses in amino acid mobilization and depletion would be expected with food 
intake.  
Following exercise, two different antioxidant-related metabolites were elevated. 
Antioxidants are necessary to maintain cellular redox balance and prevent oxidative 
damage to DNA, lipids, and proteins [37]. There was a strong response of 2-
hydroxybutyrate at the intermediate and late recovery phases where the metabolite 
increased 4-fold and 4.6-fold, respectively. Elevated lipid β-oxidation, NADH/NAD+ 
imbalance, and oxidative stress following intensive endurance exercise causes 2-
hydroxybutyrate to increase [38]. Glutathione is a major endogenous antioxidant that is 
primarily responsible for reducing lipid peroxidation, and 2-hydroxybutyrate is a 




presence of 2-hydroxybutyrate at these later times suggests continued and elevated 
glutathione demand despite the cessation of exercise several hours prior, which 
demonstrates the longer lasting effects of submaximal endurance exercise on oxidative 
stress and lipid metabolism. In contrast, 2-hydroxybutyrate was elevated one hour 
following a sprint session (three 80-meter maximal sprints), but returned to baseline 
within 30 minutes [39]. Another contributor to the antioxidant response is α-tocopherol 
(vitamin E). An exogenous lipid-soluble antioxidant, α-tocopherol is notably elevated 
from baseline in the early and intermediate recovery phases (potentially due to exercise-
associated lipolysis), but lower in the late phase, which may be due to increased cellular 
uptake [40]. Both the responses in 2-hydroxybutyrate and α-tocopherol suggest an 
increased demand for cellular antioxidants in the intermediate and late recovery stages—
the antioxidant response to exercise remained elevated even four hours later.  
These findings lead to a related discussion regarding the adaptive response to 
exercise and exogenous antioxidant supplementation. Exercise increases reactive oxygen 
species (ROS) production by several times, but the adaptive response to this stimuli 
(elevated ROS) includes the activation of endogenous antioxidant defense systems, 
resulting in the upregulation of enzymatic and non-enzymatic antioxidants [41]. Within 
skeletal muscle, exercise-induced metabolic stress results in additional positive 
adaptations by activating native anti-inflammatory mechanisms, protein turnover, 
mitochondrial biogenesis, and the heat shock protein response [42]. The exercise and 
hormesis theory presents the idea that both a lack of exercise and over-training can have 
negative effects, while some moderate volume of exercise with adequate recovery is 




resting antioxidant enzyme levels and reduce oxidative stress following subsequent bouts 
of exercise [41]. Though it may seem advisable to decrease exercise-induced oxidative 
stress by increasing antioxidant intake, ingesting large dose antioxidant supplements 
during regular exercise training may be counterproductive. Large dose vitamin C and E 
supplementation has been reported to interfere with these cellular adaptations by 
scavenging ROS, thus blunting the ROS-activated adaptive response to exercise [42]. In 
fact, supra-physiological doses of vitamins C and E have been shown to cause negative 
effects and reduced performance. Vitamin C supplemented at 1 g/day reduced positive 
training adaptations to an 8-week exercise training program—supplementation reduced 
antioxidant enzymes (superoxide dismutase and glutathione peroxidase) and 
mitochondrial biogenesis in a group of sedentary men [44]. In contrast, flavonoid 
supplementation has not been shown to inhibit positive exercise adaptations to the same 
extent, and as opposed to vitamins C and E, circulating flavonoids and their metabolites 
do not behave as direct antioxidants [45]. For example, 30-day supplementation with 
lychee fruit extract containing catechins and proanthocynaidins improved running time to 
exhaustion and the subjects’ mean anaerobic threshold, whereas a combination of 
vitamins C and E resulted in a reduction in VO2max [46]. In another study comparing 
vitamin C (1 g/day) and blackcurrant juice (300 mg anthocyanins/day) intake, oxidative 
markers (catalase, superoxide dismutase, protein carbonyls) were elevated following 
vitamin C supplementation but not the blackcurrant or placebo [47]. Finally, in a 
randomized controlled crossover trial evaluating seven day supplementation of 150 g 
blueberries, 1250 mg vitamin C, and a placebo, only the blueberry treatment reduced 




was observed with vitamin C [48]. Both blackcurrants and blueberries are high dietary 
sources of anthocyanins, a sub-class of flavonoids [13].  
In the present study, we did not observe any performance benefits or differences 
in antioxidant-related metabolites due to the HFB treatment in comparison to the LFB 
control. Flavonoids exhibit anti-inflammatory and anti-oxidative effects, likely through 
downregulation of NF-κB signaling and the activation of the Nrf2/ARE pathway, 
respectively (see Chapter II, Section 3.4) [49]. The number of publications on flavonoids 
and their effects on human health and disease continues to grow [50]. Still, specifics 
regarding optimal flavonoid intake (minimum effective dose, supplement timing with 
exercise, and length of supplementation required) to have measurable changes on various 
outcome measures are still unknown [3]. In studies where the dietary intervention was 
provided chronically, it is difficult to ascertain whether beneficial effects on exercise 
were due to the last dose or an effect due to a cumulative effect of chronic intake [49]. 
Since the intestinal microbiota plays an essential role in flavonoid bioavailability and 
transformation, more time may be required for the effects of dietary flavonoid intake to 
be reflected physiologically [16].  
The metabolomics analysis did not reveal any host- or microbiota-derived 
flavonoid metabolites in the plasma. Previously, metabolites of cocoa flavan-3-ols, tea 
catechins, and berry anthocyanins have been identified in blood and urine [20,22,51–54]. 
These studies relied on the use of LC-MS, HPLC, and UPLC to separate and detect 
flavonoid and phenolic metabolites, with a few using a combination of both GC-MS and 
LC-MS. Gas chromatography is a reliable method for simultaneous measurement of 




We observed strong effects of exercise on the metabolome but were unable to capture 
nutritional differences. Unfortunately, GC methods are not optimized for separating 
larger metabolites, and the use of multiple analytical methods may be justified in order to 
cover broader range of compounds—including phenolic and flavonoid metabolites. 
However, this is often constrained by cost and limited sample volume for conducting 
multiple analyses. Ideally, multiple extraction conditions, derivatization agents, and 
analytical platforms could be employed to ensure greater coverage of the spectrum of 
metabolites as each method can be optimized for a specific class of compounds.  
Another challenge encountered in this study was with compound identification. 
While metabolomics is excellent for profiling global changes, a common challenge is that 
hundreds of features may be detected in a sample, with limited resources for compound 
identification [4]. For example, in another study, 238 metabolites were detected with a 
combination of LC-MS and GC-MS, of which 75 remained unidentified [55]. In this 
study, initial untargeted analysis yielded over 300 metabolites, which proved to be a 
major challenge in data cleaning and compound identification. An extensive catalog of 
purified standards is required for identification and quantification, but this requires 
significant dedication of time and resources [4].  
Overall, metabolomics analysis of small molecules in biological samples is a 
powerful method for profiling the metabolic response to an intervention. In this study, 
untargeted GC-MS-based metabolomics following metabolite trimethylsilylation was 
used to profile the whole array of small molecular metabolites in plasma. The metabolic 
perturbation following a one hour, submaximal cycling trial had a different response 




similar pathways, such as long chain fatty acids, responded in a similar manner. Multiple 
classes of compounds (sugars, free fatty acids, and amino acids) changed in different 
directions in response to endurance exercise, suggesting that multiple fuel substrate 
pathways are activated to varying degrees at different times in exercise and recovery. 
Changes in energy metabolites, sugars, lipids were consistent with previous literature. 
Though some metabolites like lactate and pyruvate responded rapidly to exercise and 
returned to baseline during the intermediate recovery phase, several others, many 
unidentified, were relatively low but increased significantly in the late recovery period. 
As a result, it may be interesting to explore at later times following exercise, and future 
work could include an additional measurement 24 hours post-exercise. This would be 
especially relevant for detecting more microbiome-derived metabolites, as they take 
longer to appear in circulation. In addition, the responses of the antioxidant-related 
metabolites 2-hydroxybutyrate and α-tocopherol are interesting, and it may be 
worthwhile in future work to include measures of endogenous antioxidant mechanisms 
such as glutathione peroxidase, superoxide dismutase, and oxidized/reduced glutathione. 
Finally, depending on the resources available, future studies may find that the benefits of 
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 The body of work on dietary flavonoids in health and nutrition continues to grow, 
and emerging clinical evidence is promising [1,2]. The primary activities of flavonoids 
are anti-inflammatory, antioxidative, and vasoprotective—both in the GI tract and 
systemically [3]. Due to these potential bioactive effects, flavonoid intake is of interest in 
exercise nutrition research [4]. In the case of exercise-induced GI syndrome, transient 
changes in intestinal permeability, injury, and inflammation can negatively impact 
athletic performance and recovery [5]. Thus, the purpose of this project was to investigate 
the local and systemic effects of supplemental flavonoid intake in combination with 
submaximal cycling exercise. Two additional methodologies contributed to this project: 
studies of the intestinal microbiome and circulating metabolome. 
Methods in culture-independent microbiome analysis have advanced rapidly over 
the last two decades, and new discoveries are continually made in how the intestinal 
microbiome shapes human health and disease [6]. Specifically, the gut microbiome plays 
an essential role in the biotransformation and biological effects of flavonoids [7]. For 
example, anthocyanins were originally believed to have very low bioavailability (less 
than 1%), but bioavailability was later estimated to be closer to 12% after finding over 30 
different metabolites derived from one isotopically-labelled anthocyanin, many 
attributable to the action of the gut microbiota [8]. Inter-individual variation in the gut 
microbiome also plays a significant role in flavonoid metabolism. For example, 




ellagitannins, resulting in different downstream health effects related to cardiovascular 
risk [9].  
Metabolomics profiling is a powerful tool in nutrition research that provides a 
comprehensive analysis of the metabolic response to dietary intake [10]. Polyphenols are 
structurally diverse, and one challenge in comparing different studies is that the flavonoid 
intervention can vary from purified compounds, to processed ingredients, to whole foods. 
Despite this variation, metabolomics allows for characterization of host- and microbiota-
derived metabolites, which can be correlated to observed outcomes. Peripheral tissues are 
not likely to be exposed to native flavonoids but to conjugated and transformed 
metabolites instead, and the effects of these metabolites have been found to be quite 
different from those of the parent compounds [8]. Typical levels of polyphenols in the GI 
tract are in the μM/mM range while their metabolites in circulation are expected to be in 
nM/μM range, which should be taken into account when comparing flavonoid doses in 
cell culture, animal, and clinical studies [11].  
Overall, the subjects’ estimated average flavonoid intake reflected that of the US 
population, though total flavonoids were significantly lower than the national average due 
to lower flavan-3-ol intake. Daily supplementation of 490 mg blueberry, green tea, and 
cocoa flavonoids, while similar to the amount provided in other studies, may have 
increased daily intake by 1.5 to 35 times. The subjects had low intestinal inflammation, 
which perhaps overshadowed the effects, if any, of supplemental flavonoid consumption. 
No effects of the flavonoid intervention were found on the intestinal microbiota or 
SCFA—suggesting that supplemental flavonoids may not have the same effects as 




To evaluate the effects of sub-chronic supplemental flavonoid intake, we 
conducted a double-blind, randomized, controlled crossover trial with twelve 
recreationally-active cyclists (VO2max 43.2 ± 5.9 ml/kg/min). Following submaximal 
cycling exercise, specific metabolite patterns were observed with respect to time, 
resulting in clustering of samples collected pre-exercise, post-exercise, 1-h post-exercise, 
and 4-h post-exercise. Metabolites like pyruvate and lactate changed immediately post-
exercise, while long chain fatty acids had a larger response over a longer period of time, 
and circulating amino acids decreased to a smaller extent post-exercise. Antioxidant-
related compounds like 2-hydroxybutyrate were elevated even after four hours of 
recovery, suggesting a large demand for antioxidants following exercise. With the HFB, 
we observed a trend for cyclists exerting greater force during the time trial, though no 
measures of intestinal injury, inflammation, and permeability or plasma metabolites were 
statistically significant with respect to treatment.  
One potential reason why no treatment effects were observed may be that the 
bioactive effects of flavonoids are relatively modest, requiring longer supplementation 
periods or larger sample sizes to detect a treatment effect [12]. Additionally, previous 
studies recruited subjects with pathological conditions, presumably with significantly 
greater inflammatory stress and redox imbalance, where flavonoid supplementation may 
improve these measures to a greater extent [13]. Another consideration is the degree of 
exercise intensity and stress elicited by the study design. Gastrointestinal distress is most 
commonly observed in ultra-endurance events, and studies demonstrating an elevation in 
core temperature greater than 39 °C always reported elevated intestinal permeability 




beneficial, resulting in positive adaptations through ROS-dependent mechanisms [16]. 
Thus, flavonoid supplementation may only be necessary for cases of extreme oxidative 
imbalance and strenuous exercise—when ROS production overcomes native antioxidant 
capacity, when perfusion is inadequate to meet demand, or when delaying fatigue is 
critical during competition. Consequently, future studies should consider utilizing more 
strenuous trials. Although this may prove to be a challenge for subject recruitment and 
retention, other studies have successfully implemented such trials, and it may provide the 
best and most practical insight into the effect of flavonoid intake on athletic performance. 
A strength of this study was that it was a well-controlled, crossover clinical trial 
seeking to address an unmet need. The flavonoid pre-workout product was well-received 
by study participants. The aim of the study was appropriate and practical, with potential 
findings that could affect a large population of both amateur and professional athletes. 
Additionally, this study applied multiple methods to characterize the physiological 
response to the dietary intervention by utilizing traditional biomarkers as well as -omics 
techniques. Though we observed no apparent benefit of the flavonoid pre-workout, many 
factors may have influenced these results, and previous studies demonstrating effects 
have been conducted with curcumin, fruits, and juices [17–21]. Further study is 
warranted, alongside microbiome and metabolomics analyses, if resources allow. 
Ultimately, dietary flavonoid intake through the consumption of varied fruits and 
vegetables may be the best recommendation. A diverse and well-balanced diet supplying 
natural plant bioactives through whole foods is preferable to supplementation with single 
antioxidants [3]. Unsurprisingly, the effects of a diet rich in whole fruits and vegetables, 




to polyphenols, appear to differ from those of a diet supplemented with isolated 
flavonoids or extracts. The beneficial effects reported in epidemiological studies may be 
partially due to other food components or all components acting synergistically; 
flavonoids have been shown to interact with the food matrix during digestion, which can 
alternately increase or decrease their bioavailability [22–24].  
Finally, responses to nutritional changes are highly individualized. In the field of 
sports nutrition, tailoring to personal preferences is often recommended, and individuals 
are known to respond differently to nutritional intake. Some practical considerations are 
differences in food preferences, sport-specific needs, training schedules, and seasons. 
With advances in bioinformatics and high-throughput data processing, there is potential 
to develop individualized dietary recommendations. Characteristics such as microbiome 
enterotypes may predict an individual’s response to nutrition, which leads to differential 
metabolite production, potentially explaining the varied responses within human clinical 
trials. Future studies should investigate these characteristics that determine individual 
responses and work towards developing personalized recommendations for improving 
human health and athletic performance.  
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Appendix A. Exercise-Induced Intestinal Injury, Permeability, and Inflammation 
 
Figure A-1. Study recruitment diagram. 
 
 






Figure A-2 continued. Study recruitment materials. 
 
 





Figure A-4. Schedule for clinic visits and assessments. For the food record: B – breakfast, L – lunch, D – dinner. One stool sample 






Figure A-5. Sample schedule for Day 15, the exercise trial.  
  
 
Figure A-6. Rating of perceived exertion (RPE) visual scale. 
 
 
Table A-1. Study inclusion and exclusion criteria. 
Inclusion criteria 
Male or female of any race or ethnicity between 18 to 55 years of age 
Competed in a road race or triathlon in past 12 months 
Free of chronic disease and GI conditions 
Train at least 3 times per week, 1 hour at a time on average 
Willing to prepare and consume provided pre-workout beverage daily 
Willing to avoid consumption of high flavonoid foods/supplements and NSAIDs 
during study period 





Table A-1 continued. Study inclusion and exclusion criteria. 
Exclusion criteria 
Age <18 or >55 years 
Medical history of heart disease, hypertension, diabetes, Crohn’s disease, IBS, colitis, 
celiac disease, inflammatory or autoimmune disease, and lactose intolerance 
Uncontrolled hypertension: diastolic blood pressure >95 mm Hg or systolic blood 
pressure >160 mm Hg 
For women: pregnancy, breast feeding or postpartum <6 months 
Food allergies or restrictions to treatment/placebo beverages 
Chronic use of NSAIDs 
Consumption of flavonoid supplements <1 month prior to study start 
Other conditions (medical, psychiatric, or behavioral) that may present a safety hazard 
to the participant or interfere with study participation, as determined by the principal 
investigators 
 
Table A-2. Standard curves for sugar test probes. 
Sugar Slope Intercept R2 
Sucrose 0.0257 -0.0422 0.9996 
Lactulose 0.0245 0.0355 0.9960 






Appendix B. Gut Microbiota Profile, Short Chain Fatty Acid Excretion, and 
Intestinal Inflammation 
 




















Figure B-2. Rarefaction curves of raw (A) and normalized (rarefied to minimum library 




















Table B-1. Estimated weekly intake of individual flavonoids. 
 
Class Flavonoid Mean ± SEM (mg/week) 
Flavonols 
Isorhamnetin 7.94 ± 2.14 
Kaempferol 26.41 ± 5.34 
Myricetin 3.63 ± 1.41 
Quercetin 98.49 ± 16.79 
Flavones 
Apigenin 7.23 ± 2.16 
Luteolin 4.65 ± 0.86 
Flavanones 
Eriodictyol 0.93 ± 0.20 
Hesperetin 38.01 ± 7.54 
Naringenin 41.50 ± 9.15 
Flavan-3-ols 
(-)-Epicatechin 57.31 ± 11.42 
(+)-Catechin 22.87 ± 4.97 
(-)-Epicatechin 3-gallate 22.48 ± 16.20 
(-)-Epigallocatechin 36.87 ± 25.57 
(-)-Epigallocatechin 3-gallate 76.03 ± 54.14 
(+)-Gallocatechin 2.65 ± 1.90 
Theaflavin 1.46 ± 1.12 
Theaflavin-3, 3'-digallate 1.57 ± 1.20 
Theaflavin-3'-gallate 1.36 ± 1.04 
Thearubigins 73.65 ± 56.37 
Anthocyanidins 
Cyanidin 41.06 ± 15.15 
Delphinidin  17.88 ± 6.40 
Malvidin 29.23 ± 10.09 
Pelargonidin 0.05 ± 0.01 
Peonidin 8.59 ± 2.82 
Petunidin 12.81 ± 4.40 
 
 
Table B-2. Wilcoxon signed rank sum test for flavonoid intake. 
 
Parameter Test Statistic p-value FDR-adjusted p-value 
Flavonols 12.0 0.3804 0.5706 
Flavones 13.0 0.3394 0.5706 
Flavanones -6.0 0.6772 0.8126 
Flavan-3-ols -36.0 0.0024 0.0144 
Anthocyanidins -1.0 0.9697 0.9697 









Table B-3. Dependent t-test performed for fecal SCFA content. 
 
Parameter t ratio p-value FDR-adjusted p-value 
Acetic acid -0.60675 0.5563 0.8789 
Propionic acid -0.17074 0.8675 0.8789 
Butyric acid -0.69556 0.5011 0.8789 
Isobutyric acid -0.24649 0.8098 0.8789 
Valeric acid -0.22855 0.8234 0.8789 
Isovaleric acid -0.15598 0.8789 0.8789 
Caproic acid -0.3123 0.7607 0.8789 
Total SCFA -0.58098 0.5730 0.8789 
 
 
   
Table B-4. Wilcoxon signed rank sum test performed for fecal calprotectin. 
 
Parameter Test statistic p-value 
Calprotectin 2.0 0.9097 
 
 
Table B-5. Firmicutes to Bacteroidetes (F:B) ratio for each subject.  
 
 HFB LFB HFB-LFB 
101 2.15 8.05 -5.90 
102 4.29 4.33 -0.04 
103 133.40 141.46 -8.06 
104 6.02 10.72 -4.70 
105 2.50 3.25 -0.74 
106 86.23 23.95 62.28 
107 19.66 10.81 8.84 
108 88.53 9.49 79.04 
109 30.38 41.76 -11.38 
111 3.83 35.89 -32.07 
112 7.37 8.50 -1.13 
113 6.90 2.73 4.17 
 
 
Table B-6. Wilcoxon signed rank sum test performed for F:B. 
 
Parameter Test statistic p-value 









Table B-7. Alpha diversity: Chao1 
 




Phylum 1.024 0.30995 0.91571 
Class 0.8607 0.39306 0.91571 
Order 0.29786 0.76682 0.91571 
Family -0.14726 0.88337 0.91571 
Genus 0.23771 0.81282 0.91571 
Species 0.10624 0.91571 0.91571 
Feature-level 0.10624 0.91571 0.91571 
 
Table B-8. Alpha diversity: Observed 
 




Phylum 0.99212 0.32518 0.9072 
Class 0.90242 0.37049 0.9072 
Order 0.86811 0.3888 0.9072 
Family 0.30339 0.76258 0.93409 
Genus 0.24628 0.80622 0.93409 
Species 0.083003 0.93409 0.93409 
Feature-level 0.083003 0.93409 0.93409 
 
 
Table B-9. Alpha diversity: Shannon 
 




Phylum 1.1667 0.24744 0.91095 
Class 0.56692 0.57265 0.91095 
Order 0.65107 0.51722 0.91095 
Family 0.30047 0.76474 0.91095 
Genus -0.37216 0.71101 0.91095 
Species -0.11229 0.91095 0.91095 









Table B-10. PERMANOVA test for unweighted UniFrac distance, within-subject 
pairwise comparisons of HFB vs. LFB (n = 3). 
 
Subject pseudo-F p-value FDR-adjusted p-value 
1 1.64 0.111 0.128 
2 2.48 0.092 0.128 
3 1.74 0.111 0.128 
4 1.64 0.090 0.128 
5 1.24 0.101 0.128 
6 1.78 0.118 0.128 
7 1.58 0.100 0.128 
8 1.24 0.228 0.232 
9 1.66 0.324 0.329 
11 1.18 0.191 0.196 
12 2.60 0.102 0.128 
13 1.65 0.118 0.128 
 
 
Table B-11. Results for independent t-tests comparing individual and total SCFA from 
the Cycling Study (CS) and the Polyphenol Study (PO).  
Note: Samples from HFB and LFB were combined together since they were not 
statistically different.  
LFD = Low flavonoid diet, HFD = High flavonoid diet. Values expressed are means ± 




CS LFD (PO) 
CS vs. LFD 
p-value* 
HFD (PO) 
CS vs. HFD 
p-value* 
Acetic acid 61.3 ± 5.5 56.2 ± 3.8 0.425 44.4 ± 2.6 0.027 
Propionic acid 20.9 ± 1.9 17.6 ± 1.4 0.154 12.5 ± 0.9 0.008 
Butyric acid 20.7 ± 2.2 16.0 ± 1.1 0.101 13.2 ± 1.0 0.020 
Isobutyric 
acid 
2.2 ± 0.3 1.7 ± 0.2 0.154 1.5 ± 0.1 0.067 
Valeric acid 2.6 ± 0.2 1.9 ± 0.2 0.021 1.6 ± 0.1 0.008 
Isovaleric 
acid 
3.1 ± 0.5 2.4 ± 0.2 0.232 2.1 ± 0.1 0.116 
Caproic acid 0.7 ± 0.2 0.9 ± 0.2 0.456 0.6 ± 0.1 0.643 


























1,2-Propanediol 2.270 0.146 0.968 20.154 2.21E-09 5.47E-09 0.230 0.875 0.967 
2-Hydroxybutyrate 0.004 0.949 0.981 56.918 2.76E-18 2.45E-17 0.246 0.864 0.967 
3-Hydroxybutyric acid 0.065 0.801 0.974 24.787 7.41E-11 2.30E-10 1.820 0.152 0.967 
alpha-tocopherol 0.068 0.796 0.974 48.512 1.11E-16 8.61E-16 0.676 0.570 0.967 
Beta-alanine 1.454 0.241 0.968 22.489 3.82E-10 9.87E-10 0.567 0.639 0.967 
Cholesterol 0.400 0.534 0.968 47.041 2.22E-16 1.37E-15 0.215 0.885 0.967 
Citrate 0.008 0.929 0.981 30.053 2.29E-12 9.45E-12 0.420 0.739 0.967 
Creatinine 0.269 0.609 0.968 9.344 3.13E-05 4.61E-05 1.547 0.211 0.967 
Dehydroabietic acid 0.397 0.535 0.968 362.820 6.18E-41 1.91E-39 0.869 0.462 0.967 
D-Glucose 3.089 0.093 0.968 23.617 1.69E-10 4.77E-10 1.832 0.150 0.967 
Disaccharide 1 RI:1983 0.027 0.872 0.976 28.157 7.68E-12 2.80E-11 1.449 0.237 0.967 
Disaccharide 2 RI:2758 0.027 0.871 0.976 4.188 8.94E-03 1.11E-02 0.850 0.471 0.967 
Erythronate 1.472 0.238 0.968 4.110 9.80E-03 1.17E-02 0.533 0.661 0.967 
Fructose 0.005 0.943 0.981 3.689 1.61E-02 1.82E-02 1.542 0.212 0.967 
Glycine 0.291 0.595 0.968 9.474 2.74E-05 4.14E-05 0.561 0.642 0.967 
Homoserine 0.002 0.965 0.981 184.590 4.95E-32 1.02E-30 0.196 0.898 0.967 
L-Alanine 0.204 0.656 0.968 29.373 3.51E-12 1.36E-11 0.168 0.918 0.967 
Lauric acid 0.128 0.724 0.974 15.778 7.70E-08 1.65E-07 1.236 0.304 0.967 
Linoleic acid C18:2 1.736 0.201 0.968 31.899 7.32E-13 3.24E-12 2.430 0.073 0.967 
L-Isoleucine 0.452 0.508 0.968 9.283 3.33E-05 4.80E-05 0.452 0.717 0.967 
L-Lactate 0.204 0.656 0.968 95.312 6.09E-24 9.44E-23 0.104 0.958 0.967 
L-Leucine 0.094 0.762 0.974 23.052 2.54E-10 6.84E-10 0.636 0.595 0.967 
L-Lysine 0.624 0.438 0.968 9.807 1.96E-05 3.03E-05 1.475 0.230 0.967 
L-Phenylalanine 0.175 0.679 0.968 13.848 4.19E-07 7.64E-07 0.975 0.410 0.967 
L-Serine 1.035 0.320 0.968 5.922 1.22E-03 1.57E-03 0.286 0.835 0.967 
L-Threonine 0.091 0.765 0.974 3.049 3.46E-02 3.83E-02 0.206 0.892 0.967 
L-Tyrosine 1.722 0.203 0.968 4.028 1.08E-02 1.24E-02 1.366 0.261 0.967 
L-Valine 0.341 0.565 0.968 27.564 1.13E-11 3.90E-11 0.462 0.710 0.967 





















Myo-inositol 0.167 0.687 0.968 40.172 6.86E-15 3.27E-14 0.161 0.922 0.967 
Myristic acid 0.065 0.801 0.974 8.898 4.94E-05 6.96E-05 1.103 0.354 0.967 
Oleic acid C18:1 1.093 0.307 0.968 44.751 6.69E-16 3.77E-15 2.148 0.103 0.967 
Oxalic acid 0.023 0.882 0.976 17.712 1.53E-08 3.65E-08 0.785 0.507 0.967 
Palmitelaidic acid 2.756 0.111 0.968 8.347 8.76E-05 1.21E-04 1.374 0.258 0.967 
Palmitic acid C16:0 1.499 0.234 0.968 47.338 1.93E-16 1.33E-15 0.646 0.588 0.967 
Phosphate 0.230 0.636 0.968 24.857 7.06E-11 2.30E-10 0.345 0.793 0.967 
Pyruvate 1.205 0.284 0.968 12.297 1.74E-06 3.00E-06 0.387 0.763 0.967 
Sorbitol 0.000 0.988 0.988 4.274 8.09E-03 1.02E-02 0.102 0.958 0.967 
Stearic acid C18:0 3.887 0.061 0.968 60.558 6.29E-19 6.50E-18 0.593 0.622 0.967 
Unknown 1 RI: 1152 0.329 0.572 0.968 11.877 2.59E-06 4.23E-06 0.640 0.592 0.967 
Unknown 10 RI:2160 9.104 0.006 0.393 88.906 3.86E-23 4.79E-22 1.088 0.360 0.967 
Unknown 11 RI:2248 0.251 0.621 0.968 14.348 2.68E-07 5.36E-07 0.534 0.660 0.967 
Unknown 12 RI:2378 0.479 0.496 0.968 4.071 1.03E-02 1.20E-02 0.789 0.504 0.967 
Unknown 13 RI:2593 0.594 0.449 0.968 833.830 2.20E-52 1.36E-50 0.187 0.905 0.967 
Unknown 14 RI:2785 2.543 0.125 0.968 14.171 3.14E-07 6.08E-07 2.542 0.064 0.967 
Unknown 15 RI:2820 0.730 0.402 0.968 8.022 1.23E-04 1.63E-04 2.639 0.057 0.967 
Unknown 16 RI:3599 0.798 0.381 0.968 14.475 2.40E-07 4.95E-07 2.950 0.039 0.967 
Unknown 17 RI:3925 0.319 0.578 0.968 8.276 9.44E-05 1.27E-04 1.307 0.280 0.967 
Unknown 2 RI:1422 1.956 0.176 0.968 17.253 2.23E-08 5.12E-08 0.734 0.536 0.967 
Unknown 3 RI:1433 0.324 0.575 0.968 14.049 3.50E-07 6.57E-07 0.088 0.967 0.967 
Unknown 4 RI:1469 4.664 0.042 0.968 24.324 1.03E-10 3.03E-10 0.691 0.561 0.967 
Unknown 5 RI:1494 0.823 0.374 0.968 10.494 9.87E-06 1.57E-05 1.110 0.352 0.967 
Unknown 6 RI:1553 0.749 0.396 0.968 41.179 4.06E-15 2.10E-14 0.093 0.963 0.967 
Unknown 7 RI:1696 1.550 0.226 0.968 4.107 9.84E-03 1.17E-02 0.315 0.815 0.967 
Unknown 8 RI:1705 0.757 0.394 0.968 11.975 2.36E-06 3.96E-06 0.125 0.945 0.967 
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Dairy Product Development Competition (Idaho Milk Processors Association)     2016 
 $5,000 first prize for Pro2Go (a high protein frozen dairy dessert) 




 Chromatography (GC, HPLC, TLC), GC-MS, UV-vis spectrophotometry, PCR, 
cell culture, ELISA, sample extractions, titrations 
Computer 
 Microsoft Office Applications (Word, Excel, Powerpoint), Windows OS, Agilent 
ChemStation, Shimadzu GC Solution, JMP statistical analysis, GraphPad Prism 
 
COURSEWORK 
 Biochemistry, Dairy Chemistry, Dairy Technology and Processing, Food 
Analysis, Food Chemistry, Food Proteins, Fundamentals of Nutrition Research, 
Nutrient and Gene Interactions, Product Development, Sensory Analysis 
 
AWARDS 
 Presidential Doctoral Research Fellowship (2014-2018) 
 Build Dairy Program Tuition Award (2014-2019) 
 Travel awards: School of Research and Graduate Studies (USU), Nutrition, 
Dietetics, and Food Science (USU), Build Dairy Program (Western Dairy Center) 
